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ABSTRACT 
 
THE EFFECT OF MATERNAL NICOTINE EXPOSURE ON CELLULAR 
SENESCENCE IN THE LUNGS OF THE OFFSPRING 
Yusrah Salie 
M. Sc thesis, Department of Medical Biosciences, University of the Western 
Cape. 
 
Several studies conducted in laboratories at the University of the Western Cape 
has demonstrated an interference with the parenchymal lung tissue of the 
offspring when exposed to nicotine (smoking cigarettes and/or Nicotine 
Replacement Therapy [NRT]), maternally i.e. during gestation and lactation. This 
in turn, decreases the amount of air sacs (alveolar number) resulting in a reduced 
surface area available for efficient gas exchange in the offspring. Since the foetus 
and offspring are only exposed to nicotine during gestation and lactation, 
emphysema-like lesions appear to develop after nicotine withdrawal in the foetus.  
 
 It has been proposed that during lung development in utero, a change in the 
“program” that controls the maintenance of lung integrity will occur in the long 
term due to the initial maternal nicotine exposure. Therefore, animals that were 
exposed to maternal nicotine resemble lungs that have undergone rapid, 
premature aging caused by cellular senescence.  Furthermore, energy metabolism 
 
 
 
 
iv 
 
and structural changes in the glycolytic pathways appear irreversibly slower 
compared to animals that were not exposed to nicotine via the mother during 
gestation and lactation, resulting in a reduction  in the anti-oxidant capacity of 
lung development. Previous studies have also shown that strong anti-oxidants 
supplemented by smoking mothers during gestation and lactation could possibly 
resist change in the “program” which controls lung development and integrity of 
the offspring in the long term. Lycopene – as a strong anti-oxidant 
supplementation have shown to decrease the alveolar volume and increase the 
alveolar surface area for better gas exchange after the offspring has been exposed 
to maternal nicotine.   
 
In this study I have treated pregnant wistar rats with nicotine, tomato juice 
(containing lycopene among other phytonutrients), and a combination of nicotine 
and tomato juice during gestation, to determine various changes in the lung 
structure  and signs of premature aging in the lungs of the offspring. I have also 
performed various staining techniques such as H&E, connective tissue and β-
galactosidase staining which indicated whether maternal nicotine exposure indeed 
induced premature cellular senescence in the lungs of the offspring.  
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CHAPTER ONE 
Literature Review 
1.1 LUNG DEVELOPMENT 
The process of lung development occurs mainly in utero for most mammalian 
species. It begins early in embryogenesis and proceeds until the final stages of 
development are reached postnatally. Subsequently, postnatal lung development 
occurs within a very different, physical environment than in utero, thus the 
transition to air breathing must have a major impact on lung development. A 
change in lung expansion is allowed mainly by tissue stretch, and this stimulus 
influences cellular proliferation, cell differentiation, and the three-dimensional 
tissue structure of the terminal gas-exchange units. The absence of this tissue 
stretch stimulus would result in the impediment of lung growth and structural 
development (Hooper et al, 2006). 
 
1.2 PHASES IN LUNG DEVELOPMENT 
In humans lung development begins at 3-4 weeks of gestation, whereas in rats it 
occurs from 11.5 days post-conception (Warburton et al., 2005). 
 
The phases of lung development can be divided into two groups, namely, prenatal 
and postnatal periods, whereby each group consists of various phases. All the 
phases of lung development show the same structural characteristics in all 
mammals.  
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1.2.1 Prenatal Pe riod 
It is increasingly evident that conditions in utero during lung development 
influences lung growth, and that any abnormality will be carried out into 
adulthood (Barker, 1995). The primary goal of lung development is to produce a 
large area for gas exchange within a relatively small thorax, which allows for 
branching morphogenesis of the airways and the formation of a vascular system  
(Hislop, 2008). The prenatal period can be divided into the: 
 
1.2.1.1  Embryonic Phase 
Embryonic Phase (1-7weeks gestation in humans): During this phase initial 
budding and branching of the lung buds form from the primitive foregut. This 
phase is all under programmed or genetic control. There is also interaction 
between pulmonary blood vessels and airways. Airways grow by dichotomous 
branching from the hilum towards the periphery. The first division takes places at 
the left and right bronchus. Terminal buds are formed by each division and have a 
similar appearance throughout this period. A similar appearance is seen in other 
species such as mice, rats, and pigs (Merkus et al, 2006). The surrounding 
mesenchyme and ectodermally derived buds is essential for normal branching 
morhogenesis and mesenchyme is also required for the final pattern of branching 
(Alescio and Cassini, 1962).  
 
The initial induction of the lung is signalled from the matrix surrounding the 
foregut of fibroblast growth factor 7 (FGF-7), which is stimulated via the 
 
 
 
 
Page | 3  
 
transcription factor TTF-1 and HNF-3β of the ectoderm. Further branching is 
induced by FGF 10 via FGF receptor 2 on the epithelium. Cleft formation is also 
involved in division via BMP-4 and fibronectin with the inhibition of FGF 10 
(Weaver et al., 2000). Epithelial growth factor (EGF) found in epithelial cells 
induces proliferation and differentiation whereas TGFβ acts as an inhibitor of 
epithelial proliferation (Maeda et al., 2007). 
 
1.2.1.2  Pseudoglandular Phase 
Pseudoglandular Phase (5-17 weeks in humans), where further branching of the 
duct system generates the presumptive conducting portion of the respiratory 
system up to the level of the terminal bronchioles. Blood vessel growth occurs by 
vasculogenesis in the mesenchyme surrounding the lung buds, which is induced 
by vascular endothelial growth factor (VEGF) produced by the epithelial cells. 
VEGF stimulates endothelial cell and Type II cell growth survival b y binding 
VEGF R2 (Tuder et al., 2006, Healy et al., 2000). This is an obligatory lung 
maintenance factor throughout lung development. Failure of blood vessel 
development will be due to the absence of VEGF receptor (Shalaby et al., 1995).  
 
1.2.1.3  Canalicular Phase  
Canalicular Phase (16-26 weeks in humans): The onset of this phase is 
characterized by extensive angiogenesis within the mesenchyme that surrounds 
the more distal reaches of the embryonic respiratory system to form a dense 
capillary network. The diameter of the airways increases with a consequent 
decrease in epithelial thickness similar to that of a cuboidal structure. The 
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terminal bronchioles branch to form several orders of respiratory bronchioles. 
Differentiation of the mesenchyme progresses down the developing tree, giving 
rise to condrocytes, fibroblasts and myoblasts (Silverman and Kuehni, 2007). 
 
The respiratory airways produced are formed by branching, but the epithelium is 
at this point much thinner in the peripheral airways, and air spaces are larger. 
Detection of surfactant is present and Type I and Type II pneumocytes allows for 
epithelial differentiation to take place. Studies have shown that underlying 
capillaries appears to be responsible for the thinning and stretching of the 
epithelium which in turn leads to differentiation (Gutierrez et al., 1999). There is 
also an increase in VEGF production and the conversion of glygogen to surfactant 
in the Type II cells, which is controlled by the transcription factor HIF2α 
(Compernolle et al., 2002). 
 
1.2.1.4  Terminal Phase  
Terminal Phase (24-38 weeks in humans), allows for more branching and growth 
of the terminal sacs or primitive alveolar ducts to occur. Continued thinning of the 
stroma brings the capillaries into apposition with the prospective alveoli.  
 
1.2.2 Postnatal Period 
The postnatal period can be divided into the: 
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1.2.2.1  Alveolar Phase 
Alveolar Phase: In some mammals alveolarisation starts before birth and proceed 
postnatally, whereas in humans, alveolarisation begins at 36 weeks of gestation 
and lasts 1-3 years postnatally. Although a certain degree of maturation of the 
lung is associated with the appearance of fully mature alveoli at 36 weeks, new 
alveoli will continue to form for approximately three years after birth. Alveolar 
formation is closely linked to the deposition of elastin in the saccular lung (Grant 
et al., 2001). At birth, a newborn infant would have developed approximately 50 
million alveoli and has the potential to expand it in number to about 250 million 
alveoli with an increase in surface area from approximately 3 to 70m2 (Grant et 
al., 2001, Langston et al., 1984).  
 
In rats and mice, alveoli form entirely after birth (Hislop, 2005). At postnatal day 
4, cells of the alveolar walls show high proliferation rates. The inter-airspace 
walls consist of double capillary layers and a cellular sheet of connective tissue 
which is the basis for rapid alveolar formation from postnatal days 4 to 13, 
resulting in an increased capillary volume as well as a larger alveolar-capillary 
surface area (Bolle et al., 2008). Angiogenesis is promoted by VEGF, whereas the 
inhibition of VEGF receptor will result in a decrease in alveolar number (Jakkula 
et al., 2000). 
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1.2.2.2  Microvascular Maturation 
Microvascular Maturation (human birth – 2-3years/adulthood), where double 
capillary layers of the immature alveolar septa is reduced to a single capillary 
layer (Roth-Kleiner et al, 2003). In rats, the finalization of septal restructuring is 
complete at around postnatal day 21 (Bolle et al., 2008). The double capillary 
network that merges into a single layer is an important event in postnatal lung 
growth as angiogenesis and alveolarization goes hand in hand (Joshi and Kotecha, 
2007). 
 
1.2.2.3  Stage of Late Alveolarization 
Stage of Late Alveolarization (3-5 years to young adult age in humans): Alveolar 
formation appears to continue by peripheral (perhaps repetitive) septation at a 
slow pace (Burri, 2006). 
 
1.3 WINDOWS OF PLASTICITY DURING LUNG DEVELOPMENT 
The respiratory system consists of approximately 40 different cell types with 
multiple functions. Common air pollutants such as airborne particles, oxidant 
gases, and environmental tobacco smoke exposure affects the fetus and impacts 
on target cells, which are likely to affect critical signals or mediators expressed 
during distinct stages of lung development. Consequently, it impacts the pre- and 
postnatal periods of life in the offspring (Pinkerton and Joad, 2006). Studies have 
shown that the anti-oxidant capacity of the developing lung is low during most of 
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its development, but rapidly increases just before birth (Barker, 1995). There is 
also a natural neonatal susceptibility to environmental pollutants due to direct or 
indirect hits on a number of cell types to influence cell differentiation, 
proliferation and/or maturation (Pinkerton and Joad, 2006). This indicates that 
exposure to foreign substances, in utero such as nicotine, at the critical periods of 
lung development, can alter the normal “program” that controls lung growth and 
maturation. This could result in the offspring becoming more prone to diseases 
such as cardiovascular disease, and type II diabetes mellitus in their adult life, as 
well as inadequate lung maintenance (Barker, 1995). An example of the effect of a 
change in the in utero environment is that inadequate nutrient supply in utero 
leads to metabolic changes in the developing fetus that enhance their chance of 
postnatal survival in a supposedly deprived environment. These adaptions are 
generally beneficial only after birth (Somm et al., 2009). However, if the fetus is 
programmed during pregnancy to survive in an environment of low nutrient 
supply, but is born into an environment of abundant nutrient supply, they become 
more prone to adult obesity (Eriksson and Forsen, 2002). Maternal under-
nutrition, vascular diseases, drug abuse and placental pathology are of the major 
causes resulting in reduced oxygen and/or nutrient supply to the developing fetus  
and the consequent adjustment of metabolism in the offspring. Studies have 
shown that the degree and type of nutrient restriction, as well as gestational 
timing, affects the final structure of the fetal lungs. Experiments done in sheep 
showed that they had fewer, larger alveoli with thicker septa and blood-gas 
barriers in their adult life when intra-uterine growth restriction (IUGR) was 
induced. This was due to an inadequate nutrient supply from the mother during 
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gestation (Maritz and Harding, 2011). It is therefore, plausible that changes in the 
in utero environment due to maternal smoking or nicotine replacement therapy 
(NRT) may interfere with the development of the offspring and increase 
susceptibility to disease. 
 
1.4 THE ROLE OF LYSYL OXIDASE DURING LUNG 
DEVELOPMENT 
Lysyl Oxidase (LO), for example, functions by initiating the cross linking of 
collagen and elastin by oxidizing specific peptidyl lysine residues, stabilizing 
collagen or elastin fibres in the extracellular matrix, thereby playing a central role 
in lung morphogenesis and tissue repair. A LO reaction produces hydrogen 
peroxide which may possibly regulate gene expression and cell behavior. It is also 
considered a tumor suppressor gene. The molecular structure of LO is synthesized 
by the fibrogenic cells as a 46 preproenzyme. LO is a metalloenzyme that requires 
copper II (Cu II) as a cofactor for enzymatic function. Cu (Raunio et al.) binds at 
its active site: one Cu per molecule of the enzyme. Loss of Cu results in total 
inactivation of LO. Studies have shown that other divalent metals such as Cd, Fe, 
Co, Zn and Ni cannot replace Cu as a cofactor for LO (Chen et al., 2005). 
Therefore, animals that received a diet with reduced Cu showed in induction of 
lythyritic manifestation due to the reduction of elastin deposition in the lung 
which resulted from suppression in LO activity (Harris, 1986). Studies have also 
shown that the catalytic activity of LO may be suppressed by cigarette smoke 
condensate (CSC) and cadmium (Cd), which are major components of cigarette 
smoke. It has indeed been shown that smoke induced emphysema in chick lungs 
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was due to Cu deficiency, causing a disruption in lung structure (Li et al., 2011). 
This suggests that Cu is essential for the functioning of LO and thus normal lung 
growth, maintenance and aging and that a lack of adequate intake will 
compromise lung development. 
 
1.5 FACTORS AFFECTING THE DEVELOPING LUNG 
1.5.1 Chronic Obstructive Pulmonary Disease (COPD) 
Emphysema is a major pathologic feature of COPD. It is defined as the abnormal 
enlargement of alveolar air spaces and the destruction of alveolar walls. It is now 
known that fibrosis is present even with alveolar loss, and that fibroblasts of the 
alveolar are central to the remodelling process of cigarette smoke- induced 
emphysema. The pathogenesis of smoke- induced emphysema encompasses a 
culmination of an imbalance between: a) proteolytic and antiproteolytic 
mechanisms, b) imbalance between oxidative damage and anti-oxidative repair 
mechanisms and, c) an imbalance between cell proliferation and apoptosis of 
alveolar cells. These processes are modified by cellular senescence and infection 
(Sirianni et al., 2006). A lung with COPD presents with an increased number of 
neutorophils, macrophages and lymphocytes. Recent research raises the concern 
whether the increased numbers of potentially protective cells are directly targeted 
because of cigarette smoke or if it is a secondary response to cellular and 
molecular alterations induced by cigarette smoke inhalation (Tuder et al., 2006). 
Reactive oxygen species (ROS) and tobacco components activates a series of 
receptor-mediated signal transduction pathways, consequently causing an 
impairment of a variety of cell signalling and cytokine networks, which 
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subsequently leads to alveolar destruction, airway remodelling and chronic airway 
responses with mucus production (Yoshida et al, 2007).  
 
Cigarette smoke is a highly complex mixture of about 4,000 compounds, 
including free radicals. Long- lived radicals present in aqueous extracts of cigarette 
smoke that is cytotoxic cause’s protein and DNA damage. DNA fragmentation 
and protein damage are the hallmarks of emphysema (Banerjee et al., 2008). 
Chronic bronchitis, which is characterized by mucus production leading to cough 
with expectoration, and emphysema are both classified as representatives of 
COPD. Both result in a lowered forced expiratory volume (FEV1) (Yamaya et al., 
2007). Studies have shown that the FEV1 in smokers decrease by 50 to 100mL per 
year. This is significantly faster than the 20mL per year with normal aging (Ito 
and Barnes, 2009). COPD is the largest recognized public health problem 
worldwide, being the fifth leading cause of death in the world as reported by the 
WHO in 2002. It is a disabling condition associated with progressive airflow 
limitation that is largely irreversible. Many researchers, health care planners and 
clinicians view COPD as a self- inflicted disease by smoking. Surveys have shown 
that 11% of patients who have severe COPD, smoked more than 20 cigarettes  per 
day (Viejo-Banuelos et al., 2006). Furthermore, an important aspect of patients 
with COPD is the lack of knowledge regarding this disease which could either be 
due to them being reluctant to consult their physician for respiratory problems or 
are unconscious of their condition (Viejo-Banuelos et al., 2006). 
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1.5.1.1  Epithelial and Endothelial Cells 
Pulmonary alveolar walls are composed of Type I and Type II epithelial cells, 
endothelial cells and fibroblasts. This exceptional structure becomes susceptible to 
potential mechanisms for pathogenic dysfunction when exposed to cigarette 
smoke, consequentially compromising all alveolar septal cells (Tuder et al., 2006). 
Studies on patients with COPD showed that they have a reduced proliferation rate  
of alveolar epithelial and endothelial cells, which indicates that cigarette smoke 
not only causes injury to the lungs, but also impairs the healing process. It has 
been hypothesized that cigarette smoke induces fibroblast senescence, which is a 
biological state related to cell longevity but has a reduced ability to proliferate 
(Tsuji et al., 2004). 
 
1.5.2 Pathogenesis of Emphysema   
Emphysema is a distinctive feature of the lung-destructive process which is 
associated with the spectrum of chronic obstructive pulmonary diseases.  The 
major characteristics of emphysema involve an abnormal enlargement of the 
alveoli of the lung distal to terminal bronchioles, associated with the destruction 
of the alveolar walls. Two major forms of emphysema have been identified: 1.) 
panacinar emphysema, which involves airspace enlargement throughout the 
acinus which arises from a deficiency in synthesis or secretion of α1-proteinase 
inhibitor, and 2.) centroacinar emphysema, which develops in the central portions 
of the acinus in close proximity to respiratory bronchioles. Centroacinar 
emphysema is the most frequent observed form of emphysema and is 
predominantly associated with prolonged exposure to cigarette smoke (Vlahovic 
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et al., 1999).  In the United States approximately 4-5 million people suffer from 
emphysema. The major challenge is that there are currently no effective 
treatments aimed at this irreversibly fatal disease (Tuder et al., 2006).  
 
1.5.2.1  Apoptosis and Cell Proliferation 
Apoptosis is known as ‘programmed cell death’, which plays a role during 
developmental stages as well as aging to maintain cell populations in tissues, 
thereby contributing to homeostasis. Damaged cells caused by diseases or noxious 
agents are also controlled by apoptosis, whereby it acts as a defence mechanism 
(Norbury and Hickson, 2001). Recently the role of pulmonary emphysema has 
been highlighted. Studies have shown that emphysematous lungs are associated 
with increased levels of apoptosis in alveolar epithelial and endothelial cells 
(Yokohori et al., 2004). As a result, the integrity of the alveolar structure in the 
lungs decreases and therefore needs to be maintained due to the loss of alveolar 
cells by apoptosis. To compensate for alveolar loss, cell proliferation will 
consequently increase (Tsuji et al., 2006). Supporting studies showed that patients 
with emphysematous lungs had high levels of cell proliferation than in patients 
with normal lungs (Imai et al., 2005). For that reason, there is a direct correlation 
between apoptosis and cell proliferation in the pathogenesis of emphysema. 
However, cellular and molecular mechanisms of pathophysiology of 
emphysematous lung damage remain enigmatic.  
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1.5.2.2  Phenotypic Changes in Fibroblasts 
Fibroblasts play an important role in the maintenance of alveolar structure, and a 
change in fibroblast phenotype could be involved in the pathogenesis of 
emphysema (Muller et al., 2006). Studies have shown that lung fibroblasts from 
patients with emphysema show a reduced proliferation rate, altered growth factor 
response, and a lower number of population doublings in long-term culture (Holz 
et al., 2004). Together with clinical observations, these findings lend support to 
the hypothesis that premature aging of fibroblasts is involved in the pathogenesis 
of emphysema. Senescent cells not only lose their ability to divide and respond to 
mitogenic stimuli, but also display alterations in morphology and metabolic 
profile (Bird et al, 2003). This phenotype can be induced by oxidative stress, in 
association with epigenetic changes in gene expression. As fibroblasts provide 
part of the integrity of the lung, a senescent phenotype could affect tissue 
microbalance and structural maintenance (Muller et al., 2006). 
 
1.5.2.3  Proteinase-Antiproteinase Balance 
As mentioned, the pathogenesis of emphysema is also largely due to an imbalance 
between proteinase enzymes released from inflammatory cells and protective 
proteins, i.e. antiproteinases found in the interstitial and extracellular spaces of the 
lung. This occurs when an antiproteinase, known as A1AT (alpha-1-antitrypsin) is 
inactivated by substances contained in tobacco smoke and exposed to lung tissue. 
The alveolar structures of the lower respiratory tract in normal individuals are 
protected from endogenous proteinases such as neutrophil elastase, cathepsin G 
and proteinase-3 (Knight et al., 1997). 
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However, in the smoking individual, A1AT is synthesized in the liver and then 
transported to the lungs via the bloodstream simultaneously with inflammatory 
leukocytes such as neutrophils and macrophages. It is usually identified with an 
early onset of emphysema. SLPI (secretory leukocyte peptidase inhibitor) and 
elafin are small molecules also playing roles as proteinase inhibitors, where it is 
closely associated with elastin fibres in the extracellular matrix of the lung, and 
functions to protect the connective tissue matrix against surface-bound neutrophil 
elastase 3 (NE3), a proteinase of the lung due cigarette exposure (Knight et al., 
1997). Interference with the synthesis and function of these molecules will thus 
result in impaired maintenance of the lung structure. Studies have, for example, 
shown that cigarette smokers with an A1AT deficiency experience a greater rate 
of deterioration in lung function (Knight et al., 1997, Janus et al., 1985).   
 
1.6 OXIDANT-ANTIOXIDANT CAPACITY OF THE LUNG 
1.6.1 Tobacco Smoking as a Source of Oxidants 
Each puff of cigarette smoke contains 4000 toxic compounds, with 1015 oxidants 
in the gas phase and 1018 per gram of tar. Amongst these are potent oxidants such 
as hydrogen peroxide, hydroxyl anion and organic radicals (Tuder et al., 2006). 
Oxygen is a highly reactive atom capable of becoming part of potentially 
damaging molecules known as ‘free radicals’. Free radicals are electrically 
charged molecules with an unpaired electron and attacks healthy body cells 
causing loss of structure and function. This can be neutralized and controlled by 
antioxidants, which stabilizes or deactivates free radicals before attacking cells 
and is critical for maintaining optimal cellular and systemic health and well being 
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(Halliwell, 1994).   Types of reactive oxidant specie (ROS) include hydroxyl 
radical, superoxide anion, hydrogen peroxide, and various lipid peroxides  
(Callahan et al., 2001). 
 
An increased oxidant load can be induced by chronic inflammation, infections, 
allergens exposure, presence of ‘leaky gut’ syndrome, exposure to drugs or toxins 
such as cigarette smoke, pollution, pesticides and insecticides (Halliwell, 1994).  
An antioxidant overload may impair cell metabolism, function and characteristics.  
It has been shown that a common cause for aging and emphysema is oxidative 
stress. It has been noted that complex I and complex III in the  mitochondria of the 
cell is a potential source of free radicals, of which 90% is produced in vivo. 
Glutathione and enzymes such as superoxide dismutase, glutathione peroxidase 
and peroxiredoxins, a set of antioxidant defenses, maintains homeostasis by 
reducing free radicals (Tuder et al., 2006). When the ability of the body to 
maintain the oxidant/anti-oxidant balance is compromised through, for example, 
exposure to large quantities of oxidants via the air we inhale, or the food we eat, 
or when the anti-oxidant levels are reduced, it may result in a gradual 
deterioration of the lungs. 
 
ROS, is the major harmful substances found in cigarette smoke. There is a wide 
variety of chemicals found in cigarette smoke, the most significant of which are 
mutagens/carcinogens, PAHs (polycyclic aromatic hydrocarbons), aromatic 
amines, N-nitrosamines and aldehydes. These substances cause DNA damage by 
inducing strand breaks. ROS, are the primary causes of DNA lesions which is 
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crucial in cancer development in various organs such as cancers of the lung, oral 
cavity, nasal cavity, paranasal sinuses, larynx, stomach, pancreas, liver and kidney 
(Weng et al., 2009). 
 
Cells affected with ROS grow slower than normal. Thus, a potent antioxidant 
response of a normal, fully functional lung epithelial cell should effectively 
protect it against ROS. However, increased ROS might cause a transformation in 
epithelial cells if the antioxidant defences are overwhelmed substances, such as 
hydroquinone and catechol, present in high concentrations in tobacco smoke 
(Dennis et al., 2005). 
 
1.6.2 Nutritional Supplementation as a Source of Antioxidants 
The anti-oxidant capacity of organs, such as the lungs can become depleted when 
the dietary supply is inadequate, especially when the individual is exposed to 
chronic oversupply of oxidants such as smoking. This can be prevented by 
supplementing the diet with: 
 
1.6.2.1  Vitamin C 
Vitamin C is a water-soluble antioxidant; it occurs in extracellular fluids and is 
known as ascorbic acid. We depend on ascorbic acid for many aspects of our 
biochemical functioning. Humans, unlike many animals, cannot produce their 
own supply of vitamin C. This can cause a Vitamin C deficiency resulting scurvy, 
if it is not obtained in our diet such as fruits and vegetables. Vitamin C helps the 
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immune system to fight off foreign invaders and tumour cells; it also supports the 
cardiovascular system by facilitating fat metabolism and protecting the tissues 
from free radical damage (Becher and Winsel, 1989). Vitamin C "scavenge" 
aqueous peroxyl radicals before it can cause damage to the cell membranes. It 
works along with vitamin E, a fat-soluble antioxidant, and the enzyme glutathione 
peroxidase to stop free radical chain reactions (Becher and Winsel, 1989). 
 
Vitamin C also protects the DNA of the cells from the damage caused by free 
radicals and mutagens. It may be especially important in this day and age of 
widespread environmental pollution because it combats the effects of many such 
toxins, including ozone, carbon monoxide, hydrocarbons, pesticides and heavy 
metals (Becher and Winsel, 1989). 
 
It appears that vitamin C fights off these pollutants by stimulating various 
enzymes in the liver that detoxify the body. In several studies, vitamin C reduced 
chromosome abnormalities in workers exposed to pollutants such as coal tar, 
styrene, methyl methacrylate and halogenated ethers. Another way in which 
vitamin C protects us is by preventing the development of nitrosamines, the 
cancer-causing chemicals that stem from the nitrates contained in many foods. It 
also prevents free radical damage in the lungs and may even help to protect the 
central nervous system from damage (Becher and Winsel, 1989). 
 
When considering smokers, it is a well accepted fact that cigarette smoke has a 
negative impact on the metabolism of vitamin C. According to Schectman and 
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colleagues (1991), people who smoke have a much lower level of ascorbic acid in 
the blood than do non-smokers. Research done by Maritz and van Wyk (1997), 
demonstrated that vitamin C protects against the some of the harmful effects that 
nicotine has on lung development in the rat model (Maritz, 1993, Maritz and van 
Wyk, 1997). It has been recommended that smokers consume 100 mg of vitamin 
C a day; they may need 200 mg or more to maintain the same concentration of 
serum ascorbate as a nonsmoker who gets 60 mg of vitamin C per day (Schectman 
et al., 1991). Vitamin C occurs in large quantities in the extracellular lining fluid 
of the lung and serves as a first line of protection against inhaled oxidants (van der 
Vliet and Cross, 2000). Exposure to nicotine result in an almost 90% decrease in 
lung vitamin C content which explains why the vitamin C intake of smokers or 
NRT (nicotine replacement therapy) must be so high. Apart from chilli peppers, 
guavas and fresh herbs containing the highest quantities of vitamin C, tomatoes 
are also an important source of vitamin C. 
 
1.6.2.2  Vitamin E 
Vitamin E is an important lipid-soluble antioxidant found in high quality whole 
grain foods and properly extracted vegetable oils. It protects membrane fatty acids 
from lipid peroxidation (Elsayed, 1987). Vitamin E is a naturally occurring 
antioxidant that is virtually free of toxicity in man. Its antioxidant properties 
reflect its ability to neutralize free radicals, including toxic oxygen intermediates, 
thereby preventing peroxidation of unsaturated lipids. Numerous animal studies 
have demonstrated that vitamin E is an important determinant of the lung's 
susceptibility to injury by various oxidants, including hyperoxia, nitric oxide, 
 
 
 
 
Page | 19  
 
ozone, paraquat, nitrofurantoin, and other oxidizing agents (Yamaoka et al., 
2008). Oxidizing substances in cigarette smoke also produce lipid peroxidation 
and various studies have shown that vitamin E-deficient rats exposed to cigarette 
smoke die prematurely compared with control animals (Pacht et al., 1986). 
Vitamin E and vitamin C interact in the lungs of animals to ensure optimal 
protection against oxidants in inhaled air (Maritz and Harding, 2011). 
 
1.6.2.3  Lycopene 
Lycopene, an anti-proliferative carotenoid in the same family as beta-carotene, is 
what gives tomatoes, pink grapefruit, apricots, red oranges, watermelon, rosehips, 
and guava their red colour. This acyclic carotenoid, which is a powerful 
antioxidant, contains 11 conjugated double bonds arranged in an all-trans 
configuration, whereby the presence of these conjugated double bonds plays an 
important role in quenching a singlet oxygen, as well as in trapping peroxyl 
radicals, thereby conferring protection against prostate cancer, breast cancer, 
artherosclerosis, and helps reduce cholesterol levels in the blood (Gitenay et al., 
2007). This polyene molecule undergoes cis-trans isomerizaton by light, thermal 
energy and chemical reactions. However, lycopene obtained from plants exist in 
all-trans configuration, the most thermodynamically stable form. In human 
plasma, lycopene is present in an isomeric mixture, with 50% as cis isomers. 
Although lycopene has no provitamin A activity, is reveals other biological 
properties such as the induction of gap-junction communication, suppress growth 
factor induced proliferation, and inhibit neoplastic transformation of normal 
human and mouse cells (Ferreira et al., 2000, Liu et al., 2003). 
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It has been shown that lycopene decrease DNA damage, as well as the 
susceptibility to oxidative stress in lymphocytes. It also decreases peroxidation or 
low density lipoprotein (LDL). However, data regarding the antioxidative effects 
of lycopene alone in biological systems are limited (Mein et al., 2008). Studies 
reported a significant inhibition of N-methyl-N-nitrosaurea-testosterone induced 
carcinogenesis in male wistar-unilever rats following consumption of tomato 
powder (13 mg/lycopene/kg diet), whereas no effects were observed with 
lycopene supplementation per se (161 mg lycopene/kg diet) (Basu and Imrhan, 
2007).  Another study demonstrated that purified lycopene was shown to act 
synergistically with other natural antioxidants like the flavonoid glabridin, the 
phenolics rosmaniric acid and carnosic acid,  in inhibiting LDL oxidation in vitro. 
This suggests that lycopene in association with other natural oxidants, such as in 
tomatoes, may be more potent in inhibiting lipid peroxidation, than lycopene itself 
(Liu et al., 2006).  
 
Lycopene is a stronger growth inhibitor than β-carotene, and has been recently 
associated with an inhibition of tumor invasion, cell proliferation, and 
angiogenesis in the lungs of nude mice injected with SK-hep1 human hepatoma 
cells. Furthermore, studies have illustrated that due to cell proliferation inhibition, 
the growth inhibitory effect of lycopene may also be attributed to the induction of 
apoptosis. Subsequently, studies revealed that lycopene (0.5-2µM) inhibited the 
growth of cigarette smoke condensate-exposed immortalized RAT-1 fibroblast 
cells by arresting cell cycle progression and inducing apoptosis (Mein et al., 
2008).Studies have shown that oxidative stress is also involved in the aging 
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process. In experimental studies, it has been confirmed that tomato juice given 
concomitantly with chronic tobacco smoke exposure completely protected 
SAMP1 mice from smoke-induced emphysema (Kasagi et al., 2006). 
 
1.7 TOBACCO SMOKING AND RESPIRATORY HEALTH 
1.7.1 Maternal Smoking and its Effect on Infancy 
Two hundred and fifty million women smoke worldwide and over 700 000 
children are born to female smokers and were thus exposed to components of 
cigarette smoke each year in the United States (Li et al., 2012). In North America, 
less than one-third of female smokers stop smoking during pregnancy. Numerous 
compounds in cigarette smoke, such as carbon monoxide, cyanide, ammonia, 
vinyl chloride and polycyclic aromatic hydrocarbons are known to be harmful, for 
both mother and fetus. However, nicotine, the main stimulant and dependence-
forming alkaloid found in tobacco is most studied (Somm et al., 2009). 
 
In 1957, the associations between maternal smoking and retarded fetal growth 
were first described. Today, maternal cigarette smoking during pregnancy is even 
more prevalent and varies widely across countries and socio-economic groups. It 
is well known that the impact of maternal smoking on the developing fetus is 
complex. Tobacco smoke may impinge on the fetus in several ways: inhaled 
nicotine causes the induction of vasoconstriction of the uteroplacental vasculature, 
which leads to uteroplacental-underperfusion, in turn, having a decreased flow of 
oxygen and nutrients to the fetus. Maternal smoking increases the levels of 
carboxyhemoglobin which reduces the tissue oxygenation of the fetus. Nicotine in 
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tobacco smoke also suppresses the mother’s appetite which results in a lesser 
energy intake by the mother, leading to a reduced energy supply to the fetus  
(Polanska and Hanke, 2004). Furthermore, nicotine causes alterations in the 
cellular growth and activity of the peripheral and central nervous systems. All 
these complications  increases the risk of abruption placenta; placenta previa; 
stillbirth; spontaneous abortion; preeclampsia; preterm delivery; intra-uterine 
growth restriction; sudden infant death syndrome and congenital malformations in 
the offspring (Polanska and Hanke, 2004). 
 
Statistics show that approximately 15-20% of women smoke during pregnancy. 
Smoking is responsible for 15% of all preterm births, 20-30% of all infants are of 
low birth weight, and a 150% increase in perinatal mortality. It was proven that 
women who stopped smoking during pregnancy are at a lower risk for most of the 
above mentioned pathologies. There is no doubt that cigarette smoking is one of 
the most important and modifiable risk factors associated with adverse perinatal 
outcomes (Andres and Day, 2000). According to South African statistics between 
1993 and 2000, the average cigarette use for smoking women was 10.5% which is 
1.7% higher than males who smoke. Smoking amongst women occurs more 
prevalently in the white race (16.6%), and occurs least in the African race (6.3%). 
Women of coloured and Indian decent smoked on average 8.8% and 9.9% 
cigarettes between 1993 and 2000, respectively (van Walbeek, 2002). 
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1.7.2 Nicotine Metabolism 
Nicotine is the tobacco plants’ natural protection from being eaten by insects. It is 
a super toxin that is more lethal than a diamondback rattlesnake’s venom, and 
three times deadlier than arsenic (Caron et al., 2005). Yet, this natural 
insecticide’s chemical structure is similar to the neurotransmitter Ach 
(acetylcholine). Within eight seconds of inhalation, one experiences cough and 
dizziness. Nicotine then arrives in the brain where a large dose of dopamine is 
generated and this immediately results in a relaxing sensation for the individual 
(Caron et al., 2005). 
 
Neuronal nicotinic receptors are members of the family of neurotransmitter-gated 
ion channels that includes GABA receptors; glycine receptors; and 5-HT3 
receptors (Karlin, 2002). Neuronal nicotinic receptor subtypes arise from different 
subunits. Eight subunits (α2-α4; α6-α10) contribute to the acetylcholine binding 
site, and four subunits (α5; β2-β4) have a structural function but contribute to the 
binding site. In rodents, ±90% of the high-affinity nicotine binding sites in the 
brain contains α4 and β2 subunits (Zoli et al., 1998). Hence, α4β2 receptors are 
the neuronal nicotinic receptor subtype most likely to participate in nicotine 
addiction, although other receptors that contain α6 or α3 subunits may also be 
involved (Parker et al., 2004).  
 
Prolonged exposure to nicotine increases binding in the rat and human brain, a 
process termed “upregulation”, which has been linked with nicotine addiction. 
Upregulation occurs in cells heterologously expressing α4β2 receptors and has 
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been further characterized in a variety of expression systems. Furthermore, a 
functional response of α4β2 receptors expressed in Xenopus oocytes decreased 
after long exposure to nicotine. Recent studies also reported that functional 
responses of α4β2 receptors expressed in mammalian cells and midbrain neurons 
is increased after long-term nicotine exposure (Vallejo et al., 2005). 
Nicotine addiction is the reason why people continue to smoke. Each cigarette 
puff taken by a pregnant woman allows nicotine to be absorbed in the 
bloodstream which readily crosses the placenta, affecting the normal 
developmental processes of the fetus. Studies have shown that certain quantities 
of nicotine that enters the fetus via the placenta lands up in the amniotic fluid via 
fetal urine and also returns to the maternal circulation for excretio n (Maritz and 
Harding, 2011).  
 
1.7.3 Glucose Metabolism: Effects of Nicotine 
Glycolysis is a process whereby glucose is converted into lactic acid in an animal 
cell. Cancer cells differs from normal cells in that it is able to maintain high levels 
of glycolysis under aerobic conditions, even under high oxygen levels. This is due 
to the fact that tumours generally outgrows its blood supply, which results in 
hypoxia, in turn increasing glycolysis which is the standard response to a lack of 
oxygen. Enhanced glycolysis is a distinctive marker for cancer progression. 
Observations suggest that there is a correlation between oncongenes (ras, myc and 
src) and enhanced glycolysis (Kondoh et al., 2005b).  
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Glycolysis taking place under anaerobic conditions is inefficient as it produces 
only two ATP molecules per glucose mole. Therefore, the increase in glycolysis  
could be a way how tumour cells counteract deleterious effects of oxidative stress 
by reducing ROS accumulation. Cumulative ROS is now recognized as a feature 
of many pathological conditions such as neurodegenerative disease, 
atherosclerosis, cancer and premature aging (Kondoh et al., 2005b). Studies 
furthermore suggest that expression of PGM or GPI (glucosphosphateisomerase), 
a glycolytic enzyme, can enhance glycolysis and bypass senescence by depletion 
of PGM or GPI to shorten the cellular lifespan (Kondoh et al., 2005b). 
 
Studies have shown that maternal nicotine exposure during gestation and lactation 
results in the suppression of glycolysis as well as glycogenolysis (Maritz, 1986, 
Maritz, 1987). It has also been reported that a reduced glycolytic pathway, as well 
as high levels of AMP (adenosine monophosphate) are associated with the 
premature onset of cellular senescence, consequently causing premature aging in 
the lungs (Zwerschke et al., 2003).  
 
1.7.4 Nicotine Replacement Therapy (NRT) 
Surveys have shown that despite the fact that 80% of smokers express some desire 
to stop smoking, only 30% actually make an attempt. Therefore, clearly, 
accessible and effective smoking cessation programs are needed (Dallery et al., 
2007). Several programmes are used such as psychological programs or a 
combination of psychological and pharmacological programmes. NRT is another 
intervention prescribed by health professionals. 
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NRT is a way of getting nicotine in the bloodstream without smoking a cigarette. 
There are many types of NRT on the market and now lately electronic cigarettes 
specifically designed to stop or reduce the withdrawal symptoms associated with 
the intake of nicotine (Stead et al., 2008). It is suggested by some that NRT during 
pregnancy is safer than smoking. As a result NRT use is being encouraged despite 
the absence of direct validation for its safety. Many pregnant women are briskly 
resorting to alternative sources of nicotine such as smokeless tobacco products 
(chewing tobacco, oral and moist snuff) or pure nicotine products (nicotine 
patches, oral inhalers, nasal sprays, lozenges, gum and sublingual tablets). NRT 
usage allows for the rise in the plasma and brain nicotine levels to be slower than 
normal smoking, however, concentrations of nicotine in the blood also declines 
much slower suggesting that the lingering effect of nicotine could possibly affect 
the surrounding tissue. Nicotine inhaler, sublingual tablets and gum result in an 
estimated blood nicotine level between 5-15ng/ml, whereas nicotine patches give 
rise to blood nicotine levels of 10 to 20ng/ml. With nicotine patches, the 
absorption of nicotine occurs in the bloodstream after approximately one hour, 
and the deposition of the skin causes a continued absorption even after removal of 
the nicotine patch. Studies have shown that maternal nicotine effortlessly crosses 
the placental barrier and can be detected in the blood circulation of the fetus at a 
concentration of 15% higher compared to maternal blood concentrations, and that 
amniotic concentrations of nicotine in humans are 88% higher than maternal 
plasma (Wickstrom, 2007).  
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For pregnant women, nicotine patches are not as highly recommended as the other 
NRT options available, such as gums and inhalers.  However, NRT is aimed at 
minimizing the exposure of the unborn baby to nicotine as well as reaching 
smoking cessation with time. Yet paediatric clinicians in epidemiological studies 
showed a high level of reluctance to NRT prescriptions (Wickstrom, 2007). Apart 
from exposure of the fetus to nicotine that enters the fetal circulation via the 
placenta, nicotine also accumulates in breast milk. Thus, during the postnatal 
period the offspring is exposed to nicotine via the mother’s milk, thereby 
lengthening the period of nicotine exposure during breastfeeding. Interestingly, 
studies showed that for breastfeeding women, there is no difference between 
cigarette smoking and NRT as it delivers the same amount of nicotine in the 
breast milk (Stead et al., 2008, Wickstrom, 2007). Although nicotine delays the 
onset of endothelial progenitor cell senescence in culture by protecting telomerase 
(Junhui et al., 2009), it is possible for it to induce premature cell senescence via a 
non-telomerase mechanism. 
 
1.8 THE EFFECT OF INDUCED-CELLULAR SENESCENCE ON THE 
AGING LUNG 
1.8.1 Cellular Senescence 
Cellular senescence is defined as a state of permanent cell-cycle  arrest induced by 
either replicative senescence or by telomere- independent signals. This state of 
irreversible growth is arrested in the G1/G0 phase of the cell cycle. Senescent cells, 
therefore, cannot respond to growth factors and becomes irreversibly resistant to 
apoptosis (programmed cell death). Structurally, they adopt distinctive 
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morphological changes which appear flat and enlarged. Furthermore, it allows for 
the induction of acidic senescence associated β-galactosidase activity (SA-β-gal). 
Physiologically, these changes causes a reduction in response to growth factors, 
and an increase of susceptibility to toxins, drugs, irradiation, stress, an altered 
level of calcium, pH changes, and membrane potential, thereby reducing the 
overall amount of cellular respiration and energy metabolism. Molecularly, 
alterations in gene expression may be observed, where senescence-associated 
secretome bring forth changes in the surrounding cells and microenvironment. 
Other altered genes of senescent cells involves plasminogen activator inhibitor 
type 1 (PAI-1), c-Myc, p16INK4a, and p53. Changes also appear in the chromatin 
structure of senescent cells, and the formation of senescence associated-
heterochromatic foci (SAHF) can be found. SAHF is correlated with a 
trymethylated lysine 9 of histone H3, heterochromatic protein 1, and high-
mobility group A protein. The formation of SAHF is due to the recruitment of 
pRb to E2F-responsive promoters and is responsible for the stable repression in 
E2F genes, possibly contributing to the irreversibility of senescence. 
Biochemically, the decrease in the rates of protein synthesis and degradation is 
due to the accumulation of modified and inactivated proteins. Also, nuclear and 
mitochondrial DNA appears to have increased levels of oxidative damage (Kong 
et al., 2011). 
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1.8.2 Types of Cellular Senescence 
Cellular senescence can either be induced dependent or independent of telomeres 
known as telomere-dependent replicative senescence, and telomere- independent 
premature senescence, respectively. 
 
Telomeres are structures composed of specialized terminal DNA sequence repeats 
(TTA GGG/CCC TAA) complexed with telomere binding proteins. It is located at 
the end of every human chromosome and becomes shorter during cell division. 
The senescence stage is reached when telomere shortening disrupts telomere 
structures (Tsuji et al., 2006). 
1.8.2.1  Telomere-Dependent Replicative Senescence 
 In telomere-dependent replicative senescence, telomeres get shortened with each 
cell division, causing the inability of DNA polymerases to replicate DNA at the 
very ends of linear chromosomes. As a result, critically shortened telomeres lose 
protection of telomere-binding proteins which leads to telomere “uncapping”. 
DNA damaged foci, containing multiple DNA damage-response proteins such as 
53BPI, yH2AX, MDCI and MREII, are found in telomeres of senescent cells. 
Therefore, uncapped telomeres are recognized as DNA breaks, consequently 
triggering a DNA damage response. Telomerase, an enzyme which is responsible 
for de novo synthesis of telomeric repeats and maintenance of telomeric length, 
can be expressed in germline, stem and cancer cells. However, it is undetectable 
in majority of normal somatic cells. An absence of telomerase is the major cause 
of replicative senescence (Kong et al., 2011). 
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1.8.2.2  Telomere-Independent Premature Senescence 
 Telomere- independent premature senescence is caused by the induction of many 
independent signals, such as aberrant activation of oncogenes, damage to 
chromatin structure, oxidative stress, DNA damage and inadequate culture 
conditions, as well as environmental stress associated with emphysema, such as 
cigarette smoke exposure and oxidants. Oxidative stress accelerates telomere 
shortening, possibly by inducing telomeric single strand breaks. These exposures 
induce alveolar cells to undergo premature senescence without telomere 
shortening (Tsuji et al., 2006, Kong et al., 2011). Since nicotine displays oxidant 
properties (Newman et al., 2002) and induce oxidant release (Maritz and Harding, 
2011) it is conceivable that it may induce premature cell senescence.  
 
1.8.2.3  Similarities between Replicative, and Stress-Induced Senescence 
Replicative and stress-induced premature senescence share common changes in 
their cell cycle regulation and morphological properties. The expression of DNA 
damage checkpoints, inflammation, stress associated genes, genes encoding 
extracellular matrix proteins and the extracellular matrix are all altered. 
Senescence is now considered as a general stress response in normal cells to 
various types of cellular damage, however, senescent cells displays a unique 
pattern of gene expression and differs from proliferating or quiescent cells (Kong 
et al., 2011). 
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1.8.3 Mechanisms of Cellular Senescence 
The molecular regulation of cellular senescence varies according to species and 
different cells types. Human fibroblasts may be taken as an example, where 
senescence is primarily caused by telomere shortening, whereas mouse fibroblasts 
are probably mediated by oxidative stress which is independent of telomere 
shortening. Contrary to this, diverse-inducing senescence stimuli are triggered 
through multiple genetic pathways, which usually seem to converge on p53 and 
pRb pathways. The inactivation of both p53 and pRb pathways are required to 
prevent the activation of senescence (Kong et al., 2011). 
 
1.8.4 Senescence and Aging of the Lung 
Biological aging is characterized by a progressive deterioration of physiological 
function in all tissues and organs over time, subsequent to developmental periods. 
It involves a variety of cellular, molecular and structural alterations based on 
several mechanisms. Although normally linked to chronological age, biological 
aging can occur earlier in life, being particularly independent from an individual’s 
chronological age. Premature aging is associated with increased susceptibility to 
major chronic diseases and ultimately, mortality (Balcombe and Sinclair, 2001, 
Kong et al., 2011). Aging and cellular senescence is closely related due to their 
shared ability to time and lifespan. It has been hypothesized that constant tissue 
regeneration leads to the accumulation of senescent cells in somatic tissues, which 
in turn limits tissue renewal and disturbs tissue homeostasis, consequently leading 
to aging. Many studies have shown that there is a relationship between 
accumulation of senescent cells and age-associated pathological conditions such 
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as osteoarthritis, arthrosclerosis, dementia, liver cirrhosis, and respiratory disease. 
However, there is still uncertainty whether the accumulation of senescent cells are 
responsible for aging, or if it is accountable for age-related diseases (Kong et al., 
2011). 
 
The aging process is also controlled by telomere checkpoints. Aged human tissue 
is an example, which is at the sites of age-related pathological conditions, or 
which are associated with stress and obesity. Recent studies have observed that 
telomerase reactivation can reverse much of the premature aging phenotypes in 
telomerase-deficient mice, signifying that telomere attrition plays an important 
role in the aging process (Kong et al., 2011). 
 
1.8.5 The Relationship between Aging and Chronic Diseases 
Since aging is a multi- faceted process which involves many intimately woven 
factors such as: a) telomere attrition, b) cumulative DNA damage, c) impairment 
of DNA repair, d) epimutations in nuclear DNA, e) mutations in mitochondrial 
DNA, f) increased rigidity of cytoskeleton, g) increased cross- linking of 
extracellular matrix, h) protein damage, i) increased production of free radicals, j) 
and accumulation of waste products, it is necessary to seem prudent when 
interpreting findings, particularly with regards to animal data since it might not be 
evaluated from a single aspect. However, there is a parallel between the processes 
involving additional support for a relationship between aging and emphysema, as 
well as demonstrating differences between phenotypes of the disease, eg. 
homogeneous versus focal alterations, of which defects are viewed in vascular 
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maintenance in patients with emphysema and genetically modified rodents 
(Karrasch et al., 2008). 
 
A variety of diseases already provides mechanistic proof which specifies a link to 
induced aging. COPD itself is a risk factor for other disorders such as 
cardiovascular disease, type II diabetes, or cognitive and functional deteriorations, 
all of which are age-related. Especially the association between arterial stiffness, 
osteoporosis and the severity of airflow obstruction has provided a supportive 
substantiation on premature aging in COPD (Vogelmeier and Bals, 2007). The 
structure and function of the human lung show a variety of alterations as part of 
the normal aging process which involves a) alveolar enlargement of air spaces; b) 
vascular remodelling; c) altered composition of extracellular matrix; d) reduced 
strength of respiratory muscles; e) impaired respiratory mechanisms; f) increased 
stiffness of chest wall; g) reduction of lung function reserves (volumes, flows) 
heterogeneity of ventilation; h) and impaired gas exchange capacity (Sprung et al., 
2006). 
 
1.8.6 The Relationship between Smoking and Cellular Senescence 
Inhaled toxins, such as cigarette smoke, SO2, O3, and NO2 injures alveolar 
epithelium. Under normal conditions, effective repair responses allows alveolar 
epithelial cells the ability to migrate, proliferate and differentiate to cover defects 
that results from injury. However, if alveolar epithelial cells are unsuccessful at 
restoring itself, then it may be presupposed that chronic lung disease would be the 
result thereof (Tsuji et al., 2004).  
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In diseases such as pulmonary emphysema and fibrosis, epithelial injury and 
regeneration are considered to prevail continually. These repeated cycles of 
epithelial cells damage proliferation and differentiation at the site of injury 
resulting in faster shortening of telomere length, in turn affecting replicative 
senescence. Moreover, stress-induced senescence may occur due to inhaled toxins 
regenerating oxidative stress and DNA damage in epithelial cells. However, once 
epithelial cells reach the senescence stage, they are no longer able to proliferate. 
Lung diseases may progress due to the cessation of repair responses in epithelial 
cells which affects the architectural and functional disruptions of alveolar 
epithelium (Tsuji et al., 2004). 
 
Studies involving single exposure to cigarette smoke extract (CSE) pointed to cell 
growth inhibition at several stages of the cell cycle without killing the cells. In 
this study it was also indicated that, while there was a decrease in proliferation, 
there was a noted increase in p53 and p21 activity. When research was done on 
multiple exposures to CSE, it was found that cell growth decreased significantly, 
to the point that it nearly ceased to grow. The cells appeared to have a flat and 
enlarged morphology with an unregulated p16 and senescence associated β-
galactosidase activity. These observations indicate that a single exposure to 
cigarette smoke will inhibit normal fibroblast proliferation, whereas multiple 
exposures seem to modify cells to a irreversible state of senescence (Tsuji et al., 
2004). This will render the lungs more susceptible to stress, such as exposure to 
oxidants. 
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Studies also suggest that cigarettes smoke induced senescence of epithelial cells 
can be inhibited by an addition of an anti-oxidant called NAC, which indicates 
that oxidative stress is involved in the signalling pathways mediating the cigarette 
smoke induced senescence (Tsuji et al., 2004). 
 
1.9 MOTIVATION FOR RESEARCH INVESTIGATION  
Several studies conducted in the laboratories at the University of the Western 
Cape demonstrated an interference with the parenchymal lung tissue of the 
offspring when exposed to nicotine via the placenta and mother’s milk. This, in 
effect, decreases the amount of air sacs (alveolar number) resulting in a reduced 
surface area available for efficient gas exchange in the lung of the  offspring. 
Although the offspring were only exposed to nicotine during gestation and 
lactation, emphysema-like lesions appear to develop after nicotine withdrawal in 
the offspring, which is after weaning on postnatal day 21. It has been proposed 
that exposure of the developing lung to nicotine changes the program that controls 
the maintenance of the structural and functional integrity of the lung as the animal 
age. It is further suggested that the lungs of these nicotine exposed offspring was 
programmed to age faster because of: 1) irreversible inhibition of glycolysis, 2) 
persistent high levels of AMP (adenosine monophosphate) during growth and 
development, 3) high levels of ROS (Maritz and Harding, 2011), and 4) genotoxic 
effects of nicotine (Demirhan et al., 2011). Previous studies have shown that 
supplementing the diet of mothers with strong anti-oxidants during gestation and 
lactation could possibly resist a change in the program which controls lung 
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development and integrity of the offspring in the long term (Maritz and Harding, 
2011). 
 
1.10 AIMS AND OBJECTIVES 
It is known that lung development goes through several phases during which it 
develops into an efficient gas-exchanger. It has been shown that maternal nicotine 
exposure during gestation and lactation, and thus during all the phases of lung 
development, adversely affect the maintenance of lung integrity in the long-term. 
The aim of this project is to: 
a) Establish whether maternal nicotine exposure during gestation, which is up 
to the saccular phase of lung development, will affect lung development in 
the short term and maintenance of structural integrity in the long term.  
b) Determine whether maternal nicotine exposure during pregnancy will 
affect cell senescence in the alveolar walls.  
c) Determine whether tomato juice supplementation will prevent the effects 
of maternal nicotine exposure on the lungs of the offspring.  
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CHAPTER TWO 
Materials and Methods 
2.1  ANIMALS AND ETHICAL CLEARANCE 
White virgin female rats (Wistar decendants) were used in the present study. They 
were housed in the animal rooms at the Department of Medical Biosciences of the 
University of the Western Cape. Ethical clearance for this study was approved by 
the Ethical Committee of the University of the Western Cape in accordance to the 
guidelines of the Medical Research Council for Animal Care. Animals were fed a 
stock diet (Epol rat cubes and water as required) throughout the intended 
experiment. Room temperature was kept at 22˚±1˚C and a day-night cycle of 12 
hours (06:00 – 18:00) was maintained.  
 
 
2.2  TREATMENT OF ANIMALS 
Animals were mated overnight and afterwards randomly assigned to a control and 
three different experimental groups. At least 7 female rats were assigned to each 
group. Treatment of all the animals commenced on day 7 after mating. The 
pregnant experimental animals were divided into 4 groups (table 2.2): Group 1 
received 1mg nicotine subcutaneously/ kg body weight/day. Group 2 received 
diluted tomato juice. Group 3 received both nicotine (1mg/ kg body weight/day) 
and diluted tomato juice. Group 4 was the control, receiving saline injections 
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subcutaneously where the volume of saline was determined by the body weight of 
the mother.  
 
 
 
Table 2.2  Treatment of animals  
 
The offspring received nicotine, lycopene and other nutrients in tomato juice only 
via the placenta and mother’s milk. Nicotine doses were not changed as the body 
weights of the animals increased during pregnancy; it remained standard 
according to the initial body weight of the female rats before mating.  Nicotine 
doses were administered via subcutaneous injections with a 1ml tuberculin 
syringe.  
 
 
 
 
 
 
 
 
 
 
 
 
Pregnant  Wistar Rats 
Group 1 (N) 2 (T)  3 (N+T)  4 (C) 
Treat ment (as 
fro m DAY 7 
after mating) 
Nicotine 
1mg/BW/kg/day 
To mato Juice  
Diluted Tomato 
Juice 
To mato Juice 
and Nicotine 1 
mg/BW/kg/day 
Control 
Saline 
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F0 GENERATION:                  
Mother exposed 
to nicoine during 
gestation. 
F1 GENERATION: 
Babies received 
nicotine via 
placenta. 
F1 GENERATION: 
Lungs of offspring 
were removed at 
postnatal days 14, 
21, 42  and 84. 
 
 
 
 
 
 
 
 
 
Figure 2.2  Rat model to illustrate that rats were exposed to nicotine and/or tomato juice in utero. F0 
rats were mated to generate the F1 offspring. The lungs of the F1 offspring were exposed 
to nicotine and/or tomato juice via the placenta and mother’s breast milk (F0 generation).  
 
The tomato juice (All Gold) containing 5.3mg lycopene/100ml was diluted 50/50 
with distilled water on a daily basis due to its content being too viscous to move 
though the drinking bottles. It was freely available for the animals to drink from 
200ml glass water bottles. The water and tomato juice intake was measured daily 
at a set time, and the average intake was recorded per week. The lycopene intake 
was calculated based on the tomato juice intake by the animals and recorded as 
the average weekly intake (mg/100g body weight/week).  Apart from lycopene 
(5.3mg/100ml tomato juice), the tomato juice also contains protein (0.8g/100ml), 
carbohydrates (3.4g/100ml), fibre (0.55g/100ml), and sodium (200mg/100ml).  
Lycopene in dietary sources mainly contains all-trans lycopene. However, 
research has shown that processed tomato products such as tomato paste and 
tomato puree contains a higher bioavailability than raw tomatoes (Boileau et al., 
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2002).  The pregnant rats within each of the experimental groups were weighed on 
a weekly basis to monitor any changes in their body weights and to determine if 
there were any abnormal changes in weights due to their different treatments.  
After birth the number of rat pups per litter was kept between 10 and 12 pups to 
ensure that the nutrient supply from the mother was adequate to support the 
normal growth and development of the offspring.  
 
2.3  LUNG EXCISION PROCEDURE  
Seven rats gave birth to seven litters within each of the four groups. At least 2 rat 
pups per litter were used for lung excision from each of the seven litters per group 
on postnatal days 14, 21, 42 and 84. 
 
To remove lung tissue, the offspring were anaesthetized with an intraperitoneal 
injection of Sodium Pentobarbitone (90mg/kg/BW). Thereafter, the trachea was 
surgically cannulated and the diaphragm punctured. The fixative (10% buffered 
formalin, pH 7.2) was allowed to flow into the lungs via the trachea while a 
transpulmonary pressure gradient of 25cm fixative was maintained. After 30 
minutes the lungs were ligated at the hilum of the lungs and removed via excision 
en bloc for morphologic and morphometric studies. The lungs were each 
separately labeled and stored in buffered formalin (pH 7.2).  
 
Buffered formalin solution was made up of 4g Sodium Phosphate (Anhydrous)  
and 6g Sodium Phosphate (dehydrogenous) added to 900ml distilled water. Once 
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the chemicals were dissolved in the water, 100ml Formaldehyde solution was 
added to make up 1000ml buffered formalin solution.  
 
2.4  DETERMINATION OF LUNG VOLUMES 
Lung volumes were measured by the fluid displacement method  (Scherle, 1970), 
whereby a 100ml beaker containing buffered formalin at a pH of 7.2 was weighed 
on a scale, and then zeroed. With the support of a surgical forceps, the extracted 
lung was then immersed in the beaker at a level of buoyancy, and the final lung 
volume was determined. Lung volumes were determined before and after the 24-
hour fixation period to detect shrinkage. Due to minimal shrinkage (<2%), data 
was not corrected for shrinkage. 
 
2.5  LUNG TISSUE PROCESSING 
Subsequent to the determination of the lung volumes, the left inferior lobe of each 
pair of lungs were surgically removed with sterile blades and then placed in 
plastic embedding cassettes for further processing. Care was take as not to 
damage the tissue during removal and processing. The lung-tissue cassettes were 
placed in a HistokinetteTM tissue processor for the dehydration of lung tissue 
through a series of agents over a period of 18 hours through an automation 
process. Tissue was immersed in a series of solutions (Table 2.5), where it was 
dehydrated a gradual increase of alcohols, deparaffinized in xylene baths, then 
embedded in wax and left to dry on a cold plate.  
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Table 2.5  Illustration of lung tissue processing procedure (below).  
AGENT TIME 
Dehydration Process  
1. 70% Ethanol 2 hours 
2. 80% Ethanol 2 hours 
3. 90% Ethanol 2 hours 
4. Absolute Ethanol 2 hours 
5. Absolute Ethanol 2 hours 
Deparaffinization Process  
6. Xylene Bath I 2 hours 
7. Xylene Bath II 2 hours 
Tissue Embedding Preparation  
8. Wax Bath I 2 hours 
9. Wax Bath II 2 hours 
 
 
2.6  TISSUE EMBEDDING AND MICROTOMY 
Subsequent to the automated tissue processing, tissues were manually removed 
from cassettes in order to begin the tissue embedding procedure. Lung tissue was 
carefully aligned and fixed into a mould block using warm wax to fill the mould. 
The mould hardened on an ice plate utilizing a tissue embedding machine. Tissue 
blocks were trimmed at right angles to enable accurate morphometric 
measurements. The paraffin tissue blocks were then cut into sections of 5µm 
thickness with a microtome for further microscopy. Every third section was used 
for morphology and morphometric evaluation. This prevented double counting of 
tissue structures. Once the sections were cut, they were floated on a warm water 
bath to remove wrinkles from the thinly cut paraffin lung tissue sections, which 
was then shifted onto a glass microscopic slide for further staining processes. 
Once slides were dried, it was placed in an oven at 80°C for ±30 minutes to allow 
fixation of lung tissue to the slide. All slides were initially examined to eliminate 
sections with evidence of inadequate preparation. A total of 32 slides for each 
postnatal group (day 14, 21, 42 and 84) were prepared and equally divided 
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amongst each of their experimental groups (control, tomato juice, nicotine, and a 
combination of nicotine and tomato juice). The lung tissue slides were then ready 
for Haematoxylin and Eosin (H&E), Collagen and β-Galactosidase staining 
techniques.  
 
2.6.1 Haematoxylin and Eosin Staining 
Table 2.6.1  Haematoxylin and Eosin Staining Protocol: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parenchymal tissue includes alveolar septa, alveolar ducts, respiratory 
bronchioles, and blood vessels with the diameter of <10µm. Samples were viewed 
at 100x magnification. Nuclei in cells stained blue and cytoplasm and red blood 
cells stained in various shades of red, pink and orange. An example of 
haematoxylin staining of lung tissue in the control group and nicotine group at 
postnatal day 84 is illustrated in Fig. 2.6.1.1.  
CHEMICAL SOLUTION TIME 
Deparaffination and Rehydration  
1. Xylene bath I 5 mins 
2. Xylene bath II 5 mins 
3. Absolute ethanol I 5 mins 
4. Absolute ethanol II 5 mins 
5. 90% Ethanol 5 mins 
6. 80% Ethanol  5 mins 
7. 70% Ethanol 5 mins 
Haematoxylin Staining  
8. Haematoxylin 15 mins 
9. Rinse in tap water  
10. Scott’s tap water 2 mins 
11. 1% Acid alcohol – destaining agent 2 mins 
Eosin Staining and Dehydration  
12. Eosin – counter stain 3 mins 
13. Rinse in tap water  
14. 80% Ethanol 2 mins 
15. 90% Ethanol 2 mins 
16. Absolute Ethanol 2 mins 
17. Xylene bath I 2 mins 
18. Xylene bath II 2 mins 
19. Mount for observation using Xylene-based permount  
and coverslip slides, covering all the tissue. 
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   Fig. 2.6.1.1   H&E Staining of Control Lung  
   
2.6.2. Connective Tissue and Collagen Staining 
The Elastica van Gieson staining kit for connective tissue was used to stain elastic 
fibers in tissue sections. It is a combination of the picrofuchsin method according 
to van Gieson and the nuclear staining technique according to Weigert’s (Table 
2.6.2). 
Table 2.6.2 Connective and Collagen Staining Protocol (below): 
 
 
 
 
 
 
 
 
 
 
 
 
CHEMICAL SOLUTION TIME 
Deparaffination and Rehydration  
1. Xylene bath I 5 mins 
2. Xylene bath II 5 mins 
3. Absolute ethanol I 5 mins 
4. Absolute ethanol II 5 mins 
5. 90% Ethanol 5 mins 
6. 80% Ethanol  5 mins 
Connective and Collagen Stain  
7. Stain with Elastin according to Weigert 10 mins 
8. Rinse under running tap water 1 min 
9. Stain with Weiger’s A&B 1:1 5 mins 
10. Rinse under running tap water 1 min 
11. Stain with Picrofuschin Solution 2 mins 
Dehydration  
12. 70% Ethanol 2 mins 
13. 80% Ethanol 2 mins 
14. 90% Ethanol 2 mins 
15. Absolute Ethanol 2 mins 
16. Xylene bath I 2 mins 
17. Xylene bath II 2 mins 
18. Mount for observation using Xylene-based  
permount and coverslip slides, covering all the tissue. 
 
19. Once dried, observe under microscope  
at 100x total magnification. 
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Assessment of nuclei (black-brown pigment), elastic fibres (black pigment), 
collagen (red pigment) and muscle (yellow pigment) were observed. Fig. 2.6.2.1 
illustrates examples of connective tissue staining in the lungs of the offspring, in 
the control and nicotine groups, at postnatal day 84.  
 
 
 
 
 
    
 
2.6.3. β-Galactosidase Staining  
The purpose of this stain was to detect senescent cells in the alveolar walls of the 
lungs. Senescent cells are indicative of aging and represent an arrested state in 
which cells remain viable but unable to proliferate. Detection of cellular 
senescence histochemically, was done by means of staining for displays of 
senescence-associated expression of β-galactosidase (SA-β-Gal) activity in the 
cells of the alveolar walls. SA-β-Gal is only present in senescent cells, not in 
presenescent, quienscent or immortal cells.  
 
2.6.3.1  Preparation for β-Galactosidase Staining  
Firstly, 10X PBS was prepared by weighing 80g NaCl, 2g KCl and 11.5g 
Na2HPO4, then solving it in 1000ml distilled water(dH20). 10ml of the prepared 
Fig.2.6.2.1  Connective Tissue Staining of Control Lung 
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10X PBS was then transferred into 900ml dH20 in order to reach a 1 in 1000 
dilution (1XPBS). 
 
Nuclear Fast Red, a chemical solution which gives the cytoplasm of tissue its red 
pigment was  prepared by adding 50g Potassium Aluminium Sulphate and 1g 
Nuclear Fast Red to 500ml dH20. The solution was then mixed until it was fully 
dissolved in the dH20, and then heated in a beaker for 30 minutes. 
 
 Subsequently, a Fixative Solution was prepared by adding 470µl staining solution 
and 25µl staining supplement to 125µl of 20mg/ml Xgal in DMF 
(Dimethylformaldehyde). When not used, it was stored in a fridge at -20°C in a 
dark glass container. 
 
On completion of the preparatory solutions, Β-Galactosidase staining was then 
conducted involving rehydration of tissue slides, tissue fixing, overnight slide 
incubation, cytoplasm staining, and dehydration processes (table 2.6.3). 
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Table 2.6.3.  β-Galactosidase Staining Protocol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Slides were then viewed under a microscope (Zeiss Axiostar Plus) for the 
development of a blue pigment along alveolar walls which is indicative of cellular 
senescence. 
 
 
 
 
 
 
 
CHEMICAL SOLUTION TIME 
Rehydration  
1. Xylene Bath I 3 minutes 
2. Xylene Bath II 3 minutes 
3. Absolute Ethanol I 3 minutes 
4. Absolute Ethanol II 3 minutes 
5. 90% Ethanol 3 minutes 
6. 80% Ethanol 3 minutes 
PBS Wash  
7. Immerse slides in the prepared 1XPBS bath 5 minutes 
Tissue Fixing  
8. In a foiled dark box, pipette droplets of the prepared 
Fixative Solution on each tissue slide, then cover to 
allow fixation. 
15 minutes 
PBS Wash  
9. Immerse slides in a new 1XPBS bath 5 minutes 
Overnight Incubation  
10. Add the prepared Staining Solution Mix to each tissue 
on each slide. Incubate overnight in a dark box at 37°C. 
24 hours 
PBS Wash  
11. After overnight incubation, immerse slides in a new 
1XPBS bath 
5 minutes 
Cytoplasm Staining  
12. Immerse slides in the prepared Nuclear Fast Red 
Solution. 
30 minutes to 60 minutes 
(preferably 60 minutes when 
staining lung tissue samples) 
Dehydration  
13. 80% Ethanol 2 minutes 
14. 90% Ethanol 2 minutes 
15. Absolute Ethanol Bath 2 minutes 
16. Xylene Bath I 2 minutes 
17. Xylene Bath II 2 minutes 
18. Mount for observation using mounting media and 
coverslip slides, covering all the tissue. 
 
Fig.2.6.3.1  β-Galactosidase of Nicotine Exposed Lung 
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2.7 MORPHOMETRIC EVALUATION 
In this study, the following morphometric techniques were used to quantify 
changes in the lungs of the offspring due to aging, nicotine exposure, and/or 
tomato juice supplementation during gestation. 
 
2.7.1  Linear Intercept (Lm) 
The Mean Linear Intercept (Lm) is a stereological method used to quantify the 
size of the alveoli in our animal models. It is the distance between alveolar walls 
and represents alveolar volume. Therefore, an increased Lm, is indicative of 
alveolar wall destruction, causing an enlargement of air spaces (alveoli), resulting 
in less surface area available for gas exchange in the lungs.  
 
2.7.1.1  Determination of linear intercept (Lm) 
o Equation: Lm = N x L/m 
o Where: 
 N = number of fields counted 
 L = length of crossline (2.02mm at 100x magnification) 
 m = sum of all intercepts 
 
A micrometer containing a crossline, placed in the eye piece of a light microscope 
(100x magnification) was used to determine the number of alveolar intercepts.  
The Lm was calculated from the number of intercepts (m) where the crossline 
passes through the alveolar wall, and the number of times the line was placed on 
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the tissue sections. An alveolar wall that touches, but does not pass through a line 
is counted as 1 intercept, and an alveolar wall which passes through a line is 
counted as 2 intercepts. 
o Example of Lm calculation: 
Field         
(N) 
Number of 
Intercepts 
1 26 
2 16 
3 22 
4 25 
5 15 
 Total: 104 
 
  
Therefore: 
   Lm  = N x L/m 
    = 2.02 x 5/104 
    = 0.097mm 
    = 97µM 
 
2.7.2 Point-Counting Method 
The point-counting approach was used to measure  Vt (tissue volume density) and 
Va (alveolar air volume density) in the lungs of the control and experimental 
offspring (Bolender et al., 1993).  
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2.7.2.1  Determination of Vt 
Vt was achieved by inserting a graticule, containing a point-counting grid in the 
eye piece of a light microscope (100x magnification). 
 
The parenchymal fraction was calculated with the grid (122 points), where the 
points that fell over the lung tissue were counted, excluding points that fell over 
the blood vessels and bronchi with diameters larger than 2mm. At least 5 non-
overlapping fields were randomly selected for point counting, for each lung tissue 
slide. 
 
o Eg of Vt Calculation: 
Field Number of 
Points 
Counted 
1 49 
2 29 
3 36 
4 48 
5 41 
 Total: 203 
   
 
 
 
 
 
 
Page | 51  
 
Therefore:  
Vt  =  total no. of points counted / total no. of fields  
 = 203 / 5 
 =  40.6 / 122 points (on grid) 
   = 33.28 % 
 
2.7.2.2  Determination of Va: 
Va was achieved by subtracting the Vt by 100 in order to determine the 
percentage of the alveolar air space and volume available in the lungs after 
exposure to maternal nicotine, tomato juice and a combination of nicotine and 
tomato juice. 
 
o Eg of Va Calculation: 
Day 14, control animals had a Vt of 33.69% 
Therefore: 
Va =  100 - Vt 
= 100 - 33.69% 
= 66.31% 
 
2.7.3 Alveolar Number (Na) 
An estimate of the Na can give an indication as to the number of alveoli in the  
the area available for gas exchange. 
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The Na was calculated in two parts, where the alveolar volume (Valv) was first 
determined from the Lm, and then the Na was determined from lung volumes 
(Lv), volume density of air (Va) and Valv (Massaro and Massaro, 2000).  
 
2.7.3.1   Determination of Na Calculation   
o Where: Valv  =  Lv  X  π/3, and  
Na  =  Lv  X  Va/Valv 
o Eg of Na Calcuation 
o Control Day 14: Lv = 1.32ml, Va = 66.81 % 
 First Equation: 
 Valv  =  Lv  X  π/3 
= 1.32ml  X  3.14/3 
= 1320µl X 3.14/3 
= 1.3x103 µl 
 Second Equation: 
 Na  =  Lv  X  Va/Valv 
= 1320µl  X  66.81/1.3x103 
= 6.7x104 alveoli 
 
2.7.4  Cellular Senescence 
After the quantification of senescent cells, it was expressed as cells/100 µm of 
alveolar wall. The total number of senescent cells per length of alveolar wall was 
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determined by using the Image J software application. Pictures were taken at 400x 
magnification and used for determining cell numbers. A line was drawn along the 
alveolar wall, where the line started at the senescent cell and ended at a senescent 
cell. The Β-galactosidase stained cell occurring between the start and the end 
points if the line was counted and the number of cells expressed as senescent 
cells/100 µm of alveolar wall.  An example of Β-galactosidase activity (dark 
stained spots along alveolar wall) was indicative that cellular senescence took 
place (see Fig. 2.7.4).  
 
 
 
 
 
 
 
   
  
This method was repeated 5-7 times for each group of animals (control, nicotine, 
tomato juice, nicotine and tomato juice exposed animals), for each age group. 
Calculations were done subsequent to the senescent cell counting method.  
 
 
 
 
Fig.2.7.4  Digital image of senescent cells 
along alveolar wall 
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2.7.4.1  Determination of Senescent Cell Count 
o Eg of Senescent Cell Calculation: 
o Equation: 
 100/length of alveolar walls  X   no. of senescent cells  
     along alveolar wall 
o Where:  
 438.49µm = length of alveolar wall 
 7 = number of cells along alveolar wall 
=  100/438.49  X  7 
=  1.60 cells/100µm alveolar wall 
 
2.7.5 Lung Compliance 
An estimate of the lung compliance is a measure of the ability of the lung to 
stretch when a volume of air is inhaled, and its ability to recoil when it is exhaled.  
Lung compliance was determined by determining the volume of the lungs of the 
control and experimental groups at different ages at a constant transpulmonary 
pressure of 25cm H2O. 
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2.7.5.1   Determination of Lung Compliance 
o Where: 
 Lv = Lung Volume of Animal 
 P = 25cm H2O (pressure constant) 
 BW = Body Weight of Animal 
 
o Eg of Lung Compliance calculation 
 Control Day 14;  
 Lv = 1.32ml;  
 BW = 25.17g  
Calculation: 
 Lung Compliance  = Lv/p ÷ BW 
= 1.32/25 ÷ 25.17 
= 0.00209 (x1000) 
= 2.1 ml/cm H2O/kg  
 
The morphometric data at postnatal day 21 was pooled since no differences were 
observed between males and females.  
 
2.8 STATISTICAL ANALYSIS 
Statistical analysis of this study is expressed as means±SEM, where differences 
between experimental groups and differences between males and females within 
experimental groups were carried out by the use of the one way analysis of 
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variance (ANOVA) for unpaired data, followed by the Student-Newman-Kuels 
test for pairwise comparisons. A probability level of P<0.05 was designated as 
significant in this study. 
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CHAPTER THREE 
Results 
 
3.1  BODY WEIGHT (BW) AND TOMATO JUICE CONSUMPTION 
(TJC) OF PREGNANT RATS 
 
3.1.1 Body Weights (BW) of Pregnant Rats  
The BW of the pregnant rats increased throughout the gestational period 
(fig.3.1.1). A gradual increase from week 0 to 3 was maintained in all 
experimental groups (P>0.05). However, at gestational week 1, the animals that 
received both nicotine and tomato juice during gestation (256.54±6.47g) had BW 
of 15.6% (P<0.05) lower than the control group (303.9±3.4g), (Fig. 3.1.1(a)).  
 
3.1.2 Tomato Juice Consumption (TJC) of Pregnant Rats 
The TJC was measured throughout the gestational period (fig 3.1.2.). At 
gestational week 2, TJC was 38.1% (P<0.05) higher in the group of pregnant 
animals receiving tomato juice only (89.42±9.88ml/week), compared to animals 
receiving both nicotine and tomato juice (55.4±8.61ml/week). Both groups 
displayed a gradual increase in TJC throughout gestational week 1 and 2. 
However, at gestational week 3, the TJC of animals receiving tomato juice only 
decreased to a point where both groups showed a similar TJC (P>0.05).  
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3.1.3 Lycopene Consumption of Pregnant Rats 
Tomato juice contains 5.3mg lycopene per 100ml. Thus it was possible to 
determine the lycopene consumption of animals who received tomato juice only, 
and a combination of nicotine and tomato juice throughout gestation (Fig. 
3.1.2(a)). The consumption of lycopene follows the same trend as the 
consumption of tomato juice. The mothers that received tomato juice only had a 
higher lycopene (mg/ml/week) consumption compared to those mothers that 
received both nicotine and tomato juice throughout the gestational period. 
However, at gestational week 2, the pregnant mothers that received both nicotine 
and tomato juice consumed 4.44 mg/ml/week lycopene, whereas those mothers 
who received tomato juice only, consumed 4.24 lycopene mg/ml/week lycopene.  
 
3.1.4 Litter Sizes at Birth of Offspring 
The number of rat pups was counted per litter at the time of birth. This was to 
determine whether nicotine exposure via the placenta, or maternal tomato juice 
supplementation during gestation affected the litter size. The control group gave 
birth to litter sizes between 14 and 16 rat pups. Mothers who received both 
nicotine and tomato juice, or tomato juice only gave birth to litter sizes between 
10 and 14 rat pups. Mothers who received nicotine during gestation gave birth to 
rat pups between 9 and 13 per litter (fig. 3.1.4).  
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Fig. 3.1.1(a) Week 3 of Gestational Period
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Fig. 3.1.1   The effect of nicotine, tomato juice as well as nicotine and tomato juice supplementation 
on maternal body weight during gestation. 
Fig. 3.1.1(a) The effect of nicotine, tomato juice as well as nicotine and tomato juice supplementation 
on maternal body weight at gestational week 2.  
Table 3.1.1 The effect of nicotine, tomato juice as well as nicotine and tomato juice supplementation 
on maternal body weight during gestation (below).  
  
 
 
 
 
 
 
 
 
 
 
Gestation C C vs. T  T C vs. N  N C vs. NT NT 
Week 0  294.5±4.50 P>0.05 266.28±6.96 P>0.05 254.28±10.00 P>0.05 249.71±14.4 
Week 1  303.9±3.4 P>0.05 280.82±4.68 P>0.05 269.42±5.73 P>0.05 256.54±6.47 
Week 2  306.75±3.49 P>0.05 315.57±4.26 P>0.05 304.58±8.52 P>0.05 289.66±6.72 
Week 3  342.8±3.21 P>0.05 354.58±6.78 P>0.05 340.25±7.35 P>0.05 339.12±13.13 
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Fig. 3.1.2. Gestational Period (Weeks)
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Fig. 3.1.2  Tomato juice consumption (TJC) of pregnant rats throughout gestation 
Fig. 3.1.3  Lycopene consumption of pregnant rats throughout gestation 
Table 3.1.2  Tomato juice and water consumption of pregnant rats throughout gestation. 
  Control(C) and Nicotine (N) groups received water.  
Tomato (T), as well as Nicotine and Tomato (NT) groups received diluted (50% water) 
tomato juice (ml/kg/week).  
 
 
 
Table 3.1.3 Lycopene consumption of pregnant rats throughout gestation.  
Tomato (T), as well as Nicotine and Tomato (NT) groups received diluted tomato juice 
(50% water) containing lycopene (mg/ml/week).  
 
 
 
 
 
 
 
 
Gestation C (water)  C vs. N  N (water)  T T vs. NT NT 
Week 0  62.5±9.24 P<0.05 36.6±2.08 76.4±21.60 P>0.05 40.4±8.37 
Week 1  60±9.35 P>0.05 57.81±13.11 89.42±9.88 P<0.05 55.4±8.61 
Week 2  47.55±1.99 P>0.05 58.95±8.46 95.82±10.79 P>0.05 83.69±18.13 
Week 3  73.66±17.1 P>0.05 40.2±3.2 87.85±5.75 P>0.05 82.69±11.00 
Gestation T NT 
Week 0  4.04 2.14 
Week 1  4.74 2.94 
Week 2  4.24 4.44 
Week 3  4.66 4.35 
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Fig. 3.1.4  Litter Sizes at Birth
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Fig. 3.1.4 Litter sizes of rats exposed to tomato juice, nicotine, and both nicotine and tomato juice at 
birth. 
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3.2  THE EFFECT OF MATERNAL NICOTINE EXPOSURE AND 
TOMATO JUICE INGESTION ON THE BW, LUNG VOLUME (Lv) 
AND BW/Lv RATIOS OF THE OFFSPRING. 
 
3.2.1 Body Weights (BW) of the Offspring 
BW changes in the offspring due to aging and the effect of maternal nicotine and 
tomato juice exposure during gestation is demonstrated in fig. 3.2.1. From birth up 
to postnatal day 42 there were no differences between male and female BW 
(P>0.05). However, from postnatal day 42 the BW of males increased faster 
compared to those of the female rats, so that at postnatal day 84, the BW of all 
male groups as shown in fig. 3.2.1(a) were significantly higher (P<0.05) than that 
of the females groups (fig 3.2.1(b)). Differences between experimental groups 
were shown mostly at postnatal day 84 (table 3.2.1).  
 
3.2.2 Lung Volumes (Lv) of the Offspring 
The effect of age, as well as maternal nicotine and tomato juice exposure during 
gestation on the lung volumes of the offspring are illustrated in Fig. 3.2.2. As 
expected, from postnatal day 14 up to postnatal day 84, there is a 6-7 fold increase 
(P<0.05) in Lv in both male and female control and experimental groups. From 
postnatal day 14 to postnatal day 42 the rate of increase of Lv was similar for all 
control and experimental groups. However, at postnatal day 84 the Lv of the male 
nicotine (11.66±1.05ml) group (fig.3.2.2 (a)) was 1.29-fold higher (P<0.05) than 
that of the control male (9.03±0.59ml) group. Also, at postnatal day 84, the Lv of 
the female offspring (fig.3.2.2 (b)) exposed to nicotine during gestation 
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(9.21±0.45ml) showed a 1.18-fold higher Lv than the control females 
(7.76±0.51ml). Furthermore, the Lv of males (11.64±0.95ml) and female 
offspring (10.1±0.67ml) that were exposed both nicotine and tomato juice during 
gestation, was at postnatal day 84 1.28-fold higher (P<0.02) compared to that of 
the control males (9.03±0.59ml) and females (7.76±0.51ml), respectively. This 
resembles the increases in BW of the rats born to mothers that received tomato 
juice during pregnancy. 
 
Differences between male and female groups were observed at postnatal day 84. 
The increase in the Lv of the nicotine exposed male rats (11.66±1.05ml) was 1.26-
fold more than the increase in Lv of (P<0.006) the nicotine exposed females 
(9.21±0.45ml). This implies that the response of the males and females to 
maternal nicotine exposure is different. Also, the Lv of the males exposed to both 
nicotine and tomato juice during gestation was 1.21-fold higher (P<0.02) than the 
female group exposed to both nicotine and tomato juice (table 3.2.2). This might 
be due to the faster increase in BW of the male rats during the same period of 
time. 
 
3.2.3 Lung Volume/Body Weight Ratios (Lv/BW) of the Offspring  
At postnatal day 14, animals exposed to nicotine showed a slightly higher 
(P<0.05) Lv/BW ratio compared to the rest of the experimental groups (table 
3.2.3). Differences in Lv/BW ratios were displayed at postnatal day 42 in the 
female group exposed to both nicotine and tomato juice (P<0.05), showing a 
slightly higher Lv/BW compared to its control. At postnatal day 84, differences 
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were also observed between males (fig. 3.2.3(a)) and females (fig.3.2.3 (b)) of the 
control group (P<0.05). This was due to changes in the body composition that 
occurred once the offspring reached maturity, where males had a relatively higher 
BW and Lv than females. 
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Fig. 3.2.1. Age (Days)
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Fig. 3.2.1  The effect of maternal nicotine and tomato juice exposure during gestation on the BW(g) 
of the male and female offspring.  
Fig. 3.2.1(a) Bar graph illustration on BW of postnatal day 84 males exposed to maternal nicotine and 
tomato juice.  
Fig. 3.2.1(b) Bar graph illustration on BW of postnatal day 84 females exposed to maternal nicotine 
and tomato juice.  
Table 3.2.1 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the body weight (g) of the male and female offspring at 
postnatal days 14, 21, 42 and 84 (below). 
 
 
 
Age (Days)  Sex C C vs. T  T C vs. N  N C vs. NT NT 
14 M 25.17±0.80 P>0.05 25.33±0.91 P<0.05 27.44±0.75 P>0.05 25.43±1.04 
14 F 25.17±0.80 P>0.05 25.33±0.91 P<0.05 27.44±0.75 P>0.05 25.43±1.04 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
21 M 35.73±0.76 P>0.05 36.71±2.15 P>0.05 37.43±1.68 P<0.05 43.78±1.59 
21 F 35.73±0.76 P>0.05 36.71±2.15 P>0.05 37.43±1.68 P<0.05 43.78±1.59 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
42 M 126.39±4.52 P<0.05 108.57±5.95 P>0.05 120.11±6.28 P>0.05 125.42±10.58 
42 F 112.83±4.22 P>0.05 111.06±7.88 P>0.05 104.72±4.79 P>0.05 108.6±5.90 
M vs. F  P<0.05  P>0.05  P>0.05  P>0.05 
84 M 216.66±12.27 P<0.05 254.53±13.46 P<0.05 270.4±15.37 P>0.05 248.04±18.67 
84 F 161.65±9.07 P<0.05 191.03±6.66 P<0.05 193.97±4.47 P<0.05 195.2±7.50 
M vs. F  P<0.05  P<0.05  P<0.05  P<0.05 
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Fig. 3.2.2. Age (Days)
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Fig. 3.2.2.  The effect of maternal nicotine and tomato juice exposure during gestation on the Lv (ml) 
of the male and female offspring.  
Fig. 3.2.2(a) Bar graph illustration on Lv of postnatal day 84 males exposed to maternal nicotine and 
tomato juice.  
Fig. 3.2.2(b) Bar graph illustration on Lv of postnatal day 84 females exposed to maternal nicotine and 
tomato juice.  
Table 3.2.2 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the lung volumes (ml) of the male and female offspring at 
postnatal days 14, 24, 42 and 84 (below). 
 
 
 
Age (Days)  Sex C C vs. T  T C vs. N  N C vs. NT NT 
14 M 1.32±0.06 P>0.05 1.50±0.07 P<0.05 1.75±0.11 P>0.05 1.51±0.09 
14 F 1.32±0.06 P>0.05 1.50±0.07 P<0.05 1.75±0.11 P>0.05 1.51±0.09 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
21 M 1.92±0.09 P<0.05 2.82±0.20 P<0.05 2.58±0.14 P<0.05 2.72±0.09 
21 F 1.92±0.09 P<0.05 2.82±0.20 P<0.05 2.58±0.14 P<0.05 2.72±0.09 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
42 M 4.93±0.29 P>0.05 4.93±0.41 P>0.05 5.24±0.55 P>0.05 5.51±0.50 
42 F 4.75±0.39 P>0.05 5.38±0.52 P>0.05 5.22±0.58 P>0.05 5.27±0.56 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
84 M 9.03±0.59 P>0.05 10.73±0.64 P<0.05 11.66±1.05 P<0.05 11.64±0.95 
84 F 7.76±0.51 P>0.05 8.88±0.44 P<0.05 8.49±0.50 P<0.05 10.1±0.67 
M vs. F  P<0.05  P<0.05  P<0.05  P<0.05 
 
 
 
 
Page | 67  
 
Fig. 3.2.3(a). Day 42 Experimental Group
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Fig. 3.2.3 The effect of maternal nicotine and tomato juice exposure during gestation on the Lv/BW 
ratio (ml/g) of the male and female offspring. 
Fig. 3.2.3(a) Bar graph illustration on Lv/BW ratio (ml/g) of postnatal day 42 males exposed to 
maternal nicotine and tomato juice.  
Fig. 3.2.3(b) Bar graph illustration on Lv/BW ratio (ml/g) of postnatal day 42 females exposed to 
maternal nicotine and tomato juice.  
Table 3.2.3 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the lung volume/body weight ratio (ml/g) of the male and 
female offspring at postnatal days 14, 24, 42 and 84 (below). 
  
 
Age (Days)  Sex C C vs. T  T C vs. N  N C vs. NT NT 
14 M 5.36±0.28 P>0.05 5.99±0.28 P<0.05 6.40±0.41 P>0.05 6.00±0.32 
14 F 5.36±0.28 P>0.05 5.99±0.28 P<0.05 6.40±0.41 P>0.05 6.00±0.32 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
21 M 5.50±0.33 P>0.05 5.77±0.35 P>0.05 6.16±0.18 P>0.05 6.93±0.25 
21 F 5.50±0.33 P>0.05 5.77±0.35 P>0.05 6.16±0.18 P>0.05 6.93±0.25 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
42 M 4.21±0.31 P>0.05 4.78±0.27 P>0.05 4.86±0.40 P>0.05 4.72±0.32 
42 F 3.91±0.20 P>0.05 4.52±0.30 P>0.05 4.26±0.30 P<0.05 4.38±0.18 
M vs. F  P>0.8  P>0.09  P>0.5  P<0.01* 
84 M 4.89±0.25 P>0.05 4.63±0.17 P>0.05 4.59±0.70 P>0.05 5.07±0.22 
84 F 4.18±0.17 P>0.05 4.26±0.21 P>0.05 4.33±0.19 P<0.05 4.73±0.20 
M vs. F  P<0.05  P>0.05  P>0.05  P>0.05 
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3.3 THE EFFECT OF MATERNAL NICOTINE EXPOSURE AND 
TOMATO JUICE INGESTION DURING GESTATION ON THE 
CHEST CIRCUMFERENCE (CC) AND CROWN-RUMP LENGTH 
(CRL), CC/CRL RATIOS, AND CC/Lv RATIOS IN THE 
OFFSPRING. 
 
3.3.1 The Chest Circumference (CC) of the Offspring 
The data in Table 3.3.1 illustrates the effect of aging, as well as maternal nicotine 
exposure, and tomato juice ingestion during gestation, on the CC of the offspring. 
At postnatal day 14, the CC of all the experimental groups was smaller than that 
of the controls (P<0.05). At postnatal day 21, animals exposed to nicotine, and to 
both nicotine and tomato juice, had a CC of between 1.11-fold to 1.20-fold 
(P<0.05) smaller than the control group, respectively (fig. 3.3.1). No differences 
in CC were observed in the female group at postnatal day 42. However, at 
postnatal day 42, the CC of the males (93±3.20mm) born to mothers that ingested 
tomato juice during gestation had a CC of 1.12-fold lower (P<0.05) than that of 
the control group (104±2.09mm).  
 
Female differences in CC between experimental groups (fig. 3.3.1 (b)) were 
observed at postnatal day 84 (P<0.05). Females that received tomato juice via the 
mother during gestation (107.76±4.25mm) had a CC lower than the control group 
(113.56±2.94mm) at postnatal day 84. Whereas females exposed to nicotine 
(120.76±4.18mm) via the placenta had a CC that is higher than that of the control 
group of the same age; and females exposed to both maternal nicotine and tomato 
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juice (128.32±4.38mm) during gestation had a CC of 1.12-fold higher than the 
control group (113.56±2.94mm), at postnatal day 84.  
 
At postnatal day 84, the response of male and female offspring to maternal 
nicotine exposure, or supplementing the mother’s diet with tomato juice or 
exposure of the mother to both nicotine and tomato juice was different. The CC of 
the nicotine exposed males (134.15±7.86mm) was higher (P<0.05) than the 
nicotine exposed females (120.76±4.18mm). Similarly, the males 
(139.21±5.58mm) exposed to both nicotine and tomato juice during gestation, had 
a CC higher (P<0.05) compared to the females (128.32±4.38mm) of the same 
group, (fig. 3.3.1 (a) and fig. 3.3.1 (b)).  
 
3.3.2 The Crown-Rump Length (CRL) of the Offspring 
The CRL (fig. 3.3.2) in the offspring at postnatal day 14 differed between groups 
(P<0.05). However, at postnatal day 21, only the group exposed to tomato juice, 
and to both nicotine and tomato juice displayed higher CRL measurements 
compared to the controls of the same age (P<0.05). At postnatal day 84, males 
exposed to both nicotine and tomato juice (196.5±4.71mm) was higher (P<0.05) 
than that of the control (184.29±3.67mm). In the 84-day-old female group, 
differences in CRL was shown in animals exposed to nicotine via the placenta, as 
well as those females exposed to both nicotine and tomato juice (P<0.05). The 
CRL of the females exposed to nicotine (179.95±1.86mm) via the placenta had a 
higher CRL than the controls (173.31±2.48mm). The data also shows that the 
females exposed to both tomato juice and nicotine (182.89±3.74mm) via the 
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placenta had a significantly higher CRL than the control group (173.31±2.48mm) 
of the same age.   
 
3.3.3 The Chest Circumference/Crown-Rump Length Ratios (CC/CRL) of 
the Offspring 
The effect of maternal nicotine exposure during gestation or supplementing the 
mother’s diet with tomato juice on the CC/CRL ratios in the offspring showed 
(fig. 3.3.3) that at postnatal day 14, no differences were apparent within 
experimental groups (P>0.05). However, at postnatal day 21, only the offspring 
exposed to nicotine via the placenta expressed a lower (P<0.05) CC/CRL ratio 
when compared to its control. At postnatal day 42, males who were born to 
females that received tomato juice only during pregnancy appeared to have a 
slightly lower (P<0.05) CC/CRL ratio in comparison to the rest to the 
experimental groups (P>0.05).  The female group that received a combination of 
nicotine and tomato juice, was the only group who had a lower (P<0.05) CC/CRL 
ratio compared to the rest of the experimental groups at postnatal day 84. Table 
3.3.3(a) and table 3.3.3(b) illustrates that no significant differences were 
established between male and female groups at postnatal day 42 and 84 (P>0.05).  
 
3.3.4 The Chest Circumference/Lung Volume Ratios (CC/Lv) of the 
Offspring 
CC/Lv ratios between males and females of all experimental groups were similar 
(P>0.05) at postnatal day 14 (fig. 3.3.4 and table 3.3.4). However, differences did 
occur within experimental groups at postnatal day 21, when compared to its 
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control group (P<0.05) as seen in fig. 3.3.4(a). Animals exposed to tomato juice 
during gestation had a CC/Lv of (27.62±1.27mm/ml) that was 1.19-fold lower 
(P<0.05) than that of the controls (33.03±1.15mm/ml). Also, the CC/Lv ratio of 
animals exposed to nicotine (26.50±1.32mm/ml) via the p lacenta was 1.24-fold 
lower than the control (33.03±1.15mm/ml). Also, the CC/Lv ratio of the offspring 
that was exposed to both maternal tomato juice and nicotine (29.09±0.86mm/ml) 
via the placenta was lower than that of the 21-day-old controls 
(33.03±1.15mm/ml). 
 
Table 3.3.4 shows that at postnatal day 42 and 84 no differences in CC/Lv ratios 
between experimental groups were apparent (P>0.05).  
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Fig. 3.3.1 The effect of maternal nicotine and tomato juice exposure during gestation on the CC 
(mm) of the male and female offspring.  
Fig. 3.3.1(a) Bar graph illustration on CC (mm) of postnatal day 84 males exposed to maternal 
nicotine and tomato juice.  
Fig. 3.3.1(b) Bar graph illustration on CC (mm) of postnatal day 84 females exposed to maternal 
nicotine and tomato juice.  
Table 3.3.1 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the chest circumference (mm) of the male and female offspring 
at postnatal days 14, 24, 42 and 84 (below). 
  
 
 
Age (Days)  Sex C C vs. T  T C vs. N  N C vs. NT NT 
14 M 70.57±1.56 P<0.05 60.83±1.50 P<0.05 67.89±2.21 P<0.05 64.05±1.68 
14 F 70.57±1.56 P<0.05 60.83±1.50 P<0.05 67.89±2.21 P<0.05 64.05±1.68 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
21 M 73.27±1.47 P>0.05 73.14±2.26 P<0.05 65.89±2.32 P<0.05 60.78±1.59 
21 F 73.27±1.47 P>0.05 73.14±2.26 P<0.05 65.89±2.32 P<0.05 60.78±1.59 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
42 M 104.7±2.09 P<0.05 93±3.20 P>0.05 100.5±2.74 P>0.05 111.2±4.54 
42 F 100.3±2.92 P>0.05 96.6±5.11 P>0.05 98.58±3.61 P>0.05 106.1±4.81 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
84 M 116.59±3.66 P>0.05 117.27±7.82 P<0.05 134.15±7.86 P<0.05 139.21±5.58 
84 F 113.56±2.94 P<0.05 107.82±4.25 P<0.05 120.76±4.18 P<0.05 128.32±4.38 
M vs. F  P>0.05  P<0.05  P<0.05  P<0.05 
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Fig. 3.3.2. Age (Days)
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Fig. 3.3.2 The effect of maternal nicotine and tomato juice exposure during gestation on the CRL 
(mm) of the male and female offspring.  
Fig. 3.3.2(a) Bar graph illustration on CRL (mm) of postnatal day 84 males exposed to maternal 
nicotine and tomato juice.  
Fig. 3.3.2(b) Bar graph illustration on CRL (mm) of postnatal day 84 females exposed to maternal 
nicotine and tomato juice.  
Table 3.3.2 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the crown-rump length (mm) of the male and female offspring 
at postnatal days 14, 24, 42 and 84 (below). 
  
 
 
Age (Days)  Sex C C vs. T  T C vs. N  N C vs. NT NT 
14 M 69.14±1.27 P<0.05 73.67±1.57 P<0.05* 78.94±1.11 P<0.05 76.48±1.59 
14 F 69.14±1.27 P<0.05 73.67±1.57 P<0.05* 78.94±1.11 P<0.05 76.48±1.59 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
21 M 93.17±0.77 P<0.05 104.57±4.09 P>0.05 94.06±2.43 P<0.05 103.81±1.27 
21 F 93.17±0.77 P<0.05 104.57±4.09 P>0.05 94.06±2.43 P<0.05 103.81±1.27 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
42 M 146.3±2.13 P>0.05 141.4±3.41 P>0.05 142.2±3.10 P<0.05 156.6±5.32 
42 F 142.8±2.59 P>0.05 1417.5±5.09 P>0.05 139.4±3.41 P<0.05 151.62±1.74 
M vs. F  P>0.05  P>0.05  P>0.05  P<0.05 
84 M 184.29±3.67 P>0.05 191.93±6.65 P>0.05 192±5.10 P<0.05 196.5±4.71 
84 F 173.31±2.48 P>0.05 176.18±2.24 P<0.05 179.95±1.86 P<0.05 182.89±3.74 
M vs. F  P<0.05  P<0.05  P<0.05  P<0.05 
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Fig. 3.3.3. Age (Days)
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Fig. 3.3.3 The effect of maternal nicotine and tomato juice exposure during gestation on the 
CC/CRL (mm/mm) of the male and female offspring.  
Fig. 3.3.3(a) Bar graph illustration on CC/CRL ratio (mm/mm) of postnatal day 84 males exposed to 
nicotine and tomato juice.  
Fig. 3.3.3(b) Bar graph illustration on CC/CRL ratio (mm/mm) of postnatal day 84 females exposed to 
nicotine and tomato juice.  
Table 3.3.3 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the chest circumference/crown-rump length (mm/mm) of the 
male and female offspring at postnatal days 14, 24, 42 and 84 (below). 
 
Age (Days)  Sex C C vs. T  T C vs. N  N C vs. NT NT 
14 M 0.89±0.03 P>0.05 0.83±0.02 P>0.05 0.86±0.02 P>0.05 0.84±0.01 
14 F 0.89±0.03 P>0.05 0.83±0.02 P>0.05 0.86±0.02 P>0.05 0.84±0.01 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
21 M 0.79±0.02 P>0.05 0.72±0.03 P<0.05 0.70±0.02 P>0.05 0.75±0.01 
21 F 0.79±0.02 P>0.05 0.72±0.03 P<0.05 0.70±0.02 P>0.05 0.75±0.01 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
42 M 0.72±0.02 P<0.05 0.66±0.02 P>0.05 0.71±0.01 P>0.05 0.74±0.01 
42 F 0.70±0.01 P>0.05 0.68±0.03 P>0.05 0.71±0.02 P>0.05 0.71±0.01 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
84 M 0.64±0.02 P>0.05 0.69±0.03 P>0.05 0.70±0.07 P>0.05 0.71±0.03 
84 F 0.66±0.01 P>0.05 0.61±0.02 P>0.05 0.67±0.02 P<0.05 0.70±0.02 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
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Fig. 3.3.4(a). Day 21 Experimental Group
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Fig. 3.3.4 The effect of maternal nicotine and tomato juice exposure during gestation on the CC/Lv 
ratio(mm/ml) of the male and female offspring.  
Fig. 3.3.4(a) Bar graph illustration on CC/Lv ratio (mm/ml) of postnatal day 21 animals exposed to 
maternal nicotine and tomato juice.  
Table 3.3.4 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomat o 
juice during gestation on the chest circumference/lung volume ratio (mm/ml) of the male 
and female offspring at postnatal days 14, 24, 42 and 84 (below). 
  
 
 
 
 
  
Age (Days)  Sex C C vs. T  T C vs. N  N C vs. NT NT 
14 M 43.94±0.87 P>0.05 42.00±2.01 P>0.05 41.25±2.76 P>0.05 44.4±2.01 
14 F 43.94±0.87 P>0.05 42.00±2.01 P>0.05 41.25±2.76 P>0.05 44.4±2.01 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
21 M 33.003±1.15 P<0.05 27.62±1.27 P<0.05 26.50±1.32 P<0.05 29.09±0.86 
21 F 33.03±1.15 P<0.05 27.62±1.27 P<0.05 26.50±1.32 P<0.05 29.09±0.86 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
42 M 22.38±1.16 P>0.05 21.43±2.26 P>0.05 22.61±2.32 P>0.05 21.82±1.86 
42 F 23.18±1.52 P>0.05 19.63±2.24 P>0.05 21.89±2.69 P>0.05 23.01±1.90 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
84 M 13.71±0.87 P>0.05 12.69±0.79 P>0.05 12.16±0.92 P>0.05 12.72±0.89 
84 F 15.09±0.52 P>0.05 12.91±0.97 P>0.05 15.19±0.93 P>0.05 13.58±0.77 
M vs. F  P>0.05  P>0.05  P<0.05  P>0.05 
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3.4 THE EFFECT OF MATERNAL NICOTINE EXPOSURE AND 
TOMATO JUICE INTAKE DURING GESTATION ON THE 
ALVEOLAR AIR (Va) AND TISSUE VOLUME (Vt) IN THE 
LUNGS OF THE OFFSPRING 
 
3.4.1 The Alveolar Air (Va) in the Lungs of the Offspring 
The Va in the lungs of the offspring rapidly increased between postnatal days 14 
and 21, then stabilized until postnatal day 84 (table 3.4.1). There were no 
differences in Va between experimental groups from postnatal day 14 to day 42 
(P>0.05). However, at postnatal day 84 (fig. 3.4.1), animals exposed to nicotine 
via the placenta had a Va (82.44±0.81%) that was higher (P<0.05) than the control 
(71.21±2.22%). Animals exposed both to nicotine and tomato juice via the 
placenta showed a Va similar to those animals exposed to tomato juice only 
(P>0.05). This means that maternal administration of tomato juice, together with 
nicotine during gestation, prevented the lungs of the offspring from the harmful 
effects of nicotine on the developing lung.  
 
3.4.2 The Tissue Volume (Vt) in the Lungs of the Offspring 
Fig. 3.4.2 illustrates the effect of aging, as well as of nicotine, tomato juice only, 
and nicotine and tomato juice, on the Vt in the lungs of the offspring. As 
expected, no differences in the experimental groups were observed at postnatal 
days 14, 21 and 42 (P>0.05). However, at postnatal day 84 (table 3.4.2), Vt of the 
control group (28.79±2.22%) was 1.64-fold higher (P<0.05) than that of the 
nicotine group (17.56±0.81%). Interestingly, the animals exposed to both nicotine 
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and tomato juice via the placenta of the mother showed a Vt similar to those 
animals exposed to tomato juice only during gestation (P>0.05). This indicates 
that supplementing the mother’s diet with tomato juice during gestation, while 
exposing the unborn offspring to nicotine, helped prevent the adverse effects that 
nicotine has when administered alone.  
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Fig. 3.4.1 The effect of maternal nicotine and tomato juice exposure during gestation on the Va in 
the lungs of the offspring. 
Table 3.4.1 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the alveolar air volume in the lungs of the offspring at postnatal 
days 14, 24, 42 and 84 (below). 
 
 
 
 
 
 
 
Fig. 3.4.2 The effect of maternal nicotine and tomato juice exposure during gestation on the Va in 
the lungs of the offspring. 
Table 3.4.2 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the alveolar air volume in the lungs of the offspring at postnatal 
days 14, 24, 42 and 84 (below).  
Age (Days)  C C vs. T  T C vs. N  N C vs. NT NT 
14 66.81±3.06 P>0.05 73.11±1.89 P>0.05 68.09±0.73 P>0.05 70.02±1.81 
21 72.65±1.29 P>0.05 73.47±4.04 P>0.05 77.47±2.24 P>0.05 76.09±0.21 
42 72.17±1.29 P>0.05 71.53±4.04 P>0.05 77.1±2.04 P>0.05 74.71±0.21 
84 71.21±2.22 P>0.05 75.9±1.28 P<0.05 82.44±0.81 P>0.05 75.08±0.33 
Age (Days)  C C vs. T  T C vs. N  N C vs. NT NT 
14 33.19±3.06 P>0.05 26.90±1.89 P>0.05 31.71±0.73 P>0.05 29.97±1.81 
21 27.35±1.29 P>0.05 26.53±4.04 P>0.05 22.53±2.24 P>0.05 23.91±0.21 
42 27.83±1.29 P>0.05 28.47±4.04 P>0.05 22.9±2.04 P>0.05 25.29±0.21 
84 28.79±2.22 P>0.05 24.1±1.28 P<0.05 17.56±0.81 P>0.05 24.92±0.33 
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3.5 THE EFFECT OF MATERNAL NICOTINE AND TOMATO JUICE 
ON THE LINEAR INTERCEPT (Lm) IN THE LUNGS OF THE 
OFFSPRING 
 
3.5.1  The Linear Intercept (Lm) in the Lungs of the Offspring  
Changes in the Lm of the lungs of the offspring as a function of age, as well as a 
result of exposure to nicotine, or to tomato juice, or to both nicotine and tomato 
juice during gestation is shown in fig. 3.5.1. The Lm measurement indicates the 
size of the alveoli in the lungs. As the animals age, it is expected for the size of 
the alveoli to gradually increase, thereby increasing the Lm. This means that the 
surface area available for gas exchange would slowly decrease. According to the 
data in fig 3.5.1, no significant differences were found in Lm between all the 
experimental and the control group at postnatal day 14 (P>0.05). However, at 
postnatal day 21, the offspring exposed to nicotine (48.32±0.76µm) via the 
placenta had an Lm that was 1.33-fold higher (P<0.05) than the control 
(36.06±0.64µm).  At postnatal day 42, no differences were observed between the 
experimental groups except for those animals exposed to nicotine during gestation 
(48.32±0.76µm), which was 1.45-fold higher (P<0.05) than in the control group 
(37.19±2.18µm). This was also observed at postnatal day 84, where the Lm of the 
nicotine exposed animals (61.84±2.81µm) was higher than that of the animals 
whose mothers received a tomato juice supplementation as well as those that were 
exposed to nicotine and was receiving a tomato juice supplementation and the 
control (38.18±2.94µm) (fig.3.5.1 (a)). The Lm those animals exposed to both 
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nicotine and tomato juice during gestation was the same as for the control animals 
(P>0.05). 
 
The results achieved in this study and those reflecting changes in Vt and Va as 
illustrated in fig. 3.4.1 and fig. 3.4.2, shows that maternal nicotine exposure 
during gestation results in a gradual degradation of lung parenchymal tissue in the 
lungs of the nicotine exposed offspring as the animals age. Interestingly, 
supplementing the mother’s diet with tomato juice, together with nicotine 
administration during gestation only prevented the harmful effects of nicotine on 
the lung tissue of the offspring. 
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Fig. 3.5.1 The effect of maternal nicotine and tomato juice exposure during gestation on the Lm 
(µm) of the offspring. 
Fig. 3.5.1(a) Bar graph illustration on Lm (µm) of postnatal day 84 animals exposed to maternal 
nicotine and tomato juice.  
Table 3.5.1 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the linear intercept (µm) of the offspring at postnatal days 14, 
24, 42 and 84 (below).  
  
 
 
 
 
 
 
 
 
 
 
 
Age (Days)  C C vs. T  T C vs. N  N C vs. NT NT 
14 33.19±3.06 P>0.05 26.89±1.88 P>0.05 31.91±0.75 P>0.05 29.90±1.25 
21 36.68±0.64 P>0.05 37.72±5.32 P<0.05 48.32±0.76 P>0.05 36.54±0.94 
42 37.19±2.18 P>0.05 37.23±1.91 P<0.05 54.29±1.55 P>0.05 39.12±3.53 
84 38.18±2.94 P>0.05 36.03±1.61 P<0.05 61.84±2.81 P>0.05 38.63±1.44 
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3.6 THE EFFECT OF MATERNAL NICOTINE EXPOSURE AND 
TOMATO JUICE INTAKE DURING GESTATION ON THE 
ALVEOLAR NUMBER (Na) IN THE LUNGS OF THE OFFSPRING 
 
3.6.1 The Alveolar Number (Na) in the Lungs of the Offspring 
Fig. 3.6.1 provides an estimate of the Na in the lungs of the offspring exposed to 
nicotine via the placenta and those offspring that received tomato juice during 
gestation. The data also showed the effect of exposure to both nicotine and tomato 
juice during pregnancy on the Na of the offspring as they grew older. As a 
function of age, the Na tends to increase with time as the body weight of the 
offspring increased. At postnatal days 14 and 21, the Na in the lungs of the control 
offspring was similar to that of all the experimental groups (P>0.05). However, as 
the animals approached postnatal day 42, the Na of the nicotine exposed group 
increased much slower than that of the control animals and in the other 
experimental groups. To illustrate; at postnatal day 42, nicotine exposed animals 
had a Na of 0.16±0.03 million which was 4.93-fold less than the control 
(0.79±0.38 million). At postnatal day 84, nicotine exposed animals had an Na of 
0.43±0.1 million which was 5.27-fold less than the control group 
(2.27±0.25million). This indicates that those offspring exposed to maternal 
nicotine during gestation, continued to suffer the effects of nicotine relatively late 
in life. Those animals exposed to both maternal nicotine and tomato juice 
however, had the same Na as the control rats (P>0.05), suggesting that tomato 
juice prevented the breakdown of the alveolar walls, thus keeping the Na within 
normal range as the animals age.  
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Fig. 3.6.1 The effect of maternal nicotine and tomato juice exposure during gestation on the Na in 
the lungs of the offspring. 
Fig. 3.6.1(a) Bar graph illustration on Na of postnatal day 84 offspring exposed to maternal nicotine 
and tomato juice.  
Table 3.6.1 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the alveolar number (x 106) in the lungs of the offspring at 
postnatal days 14, 24, 42 and 84 (below). 
  
 
 
 
 
 
 
 
 
 
Age (Days)  C (10
6
) C vs. T  T(10
6
) C vs. N  N(10
6
) C vs. NT NT(10
6
) 
14 0.21±0.03 P>0.05 0.35±0.04 P>0.05 0.3±0.02 P>0.05 0.22±0.06 
21 0.21±0.01 P>0.05 0.18±0.02 P>0.05 0.18±0.02 P>0.05 0.19±0.05 
42 0.79±0.38 P>0.05 0.64±0.09 P<0.05 0.16±0.03 P>0.05 0.95±0.18 
84 2.27±0.25 P>0.05 2.33±0.21 P<0.05 0.43±0.1 P>0.05 2.01±0.25 
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3.7 THE EFFECT OF MATERNAL NICOTINE EXPOSURE AND 
TOMATO JUICE INTAKE DURING GESTATION ON THE 
STATIC COMPLIANCE (Cst) OF THE LUNGS OF THE 
OFFSPRING 
 
3.7.1 The Static Compliance (Cst) of the Lungs of the Offspring 
Fig. 3.7.1 illustrates the effect of aging, as well as nicotine, supplementing the 
pregnant mothers diet tomato juice only, and giving her both nicotine and tomato 
juice during gestation, on the static compliance of the lungs of the offspring. No 
differences between males and females were initially observed (P>0.05).  
 
No differences (P>0.05) were observed between experimental groups at postnatal 
days 14 and 42. However, at postnatal day 84, males exposed to nicotine 
(0.466±0.040 ml/ml H20/kg) via the placenta during gestation, had a higher 
(P<0.05) Cst compared to its control (0.361±0.020 ml/ml H20/kg) (table 3.7.1(a)). 
Also, at postnatal day 84, females exposed to nicotine (0.339±0.010 ml/ml 
H20/kg) via the placental during gestation, had a higher (P<0.05) Cst than the 
control group (0.310±0.020 ml/ml H20/kg) (table 3.7.1(b)). 
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Fig. 3.7.1 The effect of maternal nicotine and tomato juice exposure during gestation on the static 
compliance (ml/ml H20/kg) of the lungs of the male and female offspring.  
Fig. 3.7.1 (a) The effect of maternal nicotine and tomato juice exposure during gestation on the static 
compliance (ml/ml H20/kg) of the lungs of the male offspring at postnatal day 84. 
Fig. 3.7.1 (b) The effect of maternal nicotine and tomato juice exposure during gestation on the static 
compliance (ml/ml H20/kg) of the lungs of the female offspring at postnatal day 84. 
Table 3.7.1 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the lung compliance (ml/ml H20/kg) of the lungs of the male and 
female offspring at postnatal days 14, 24, 42 and 84 (below). 
  
Age (Days)  Sex C C vs. T  T C vs. N  N C vs. NT NT 
14 M 0.052±0.003 P>0.05 0.057±0.003 P>0.05 0.069±0.004 P>0.05 0.060±0.003 
14 F 0.21±0.01 P>0.05 0.28±0.05 P>0.05 0.25±0.02 P>0.05 0.24±0.01 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
21 M 0.082±0.006 P<0.05 0.112±0.008 P<0.05 0.103±0.005 P>0.05 0.108±0.004 
21 F 0.21±0.01 P<0.05 0.31±0.01 P<0.05 0.28±0.001 P>0.05 0.25±0.02 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
42 M 0.197±0.010 P<0.05 0.197±0.010 P>0.05 0.209±0.020 P>0.05 0.220±0.020 
42 F 0.189±0.02 P>0.05 0.215±0.020 P>0.05 0.208±0.020 P>0.05 0.210±0.020 
M vs. F  P>0.05  P>0.05  P>0.05  P>0.05 
84 M 0.361±0.020 P>0.05 0.429±0.020 P<0.05 0.466±0.040 P<0.05 0.465±0.030 
84 F 0.310±0.020 P>0.05 0.355±0.010 P<0.05 0.339±0.010 P<0.05 0.400±0.020 
M vs. F  P<0.05  P<0.05  P<0.05  P>0.05 
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3.8 THE EFFECT OF MATERNAL NICOTINE EXPOSURE AND 
TOMATO JUICE INTAKE DURING GESTATION ON CELLULAR 
SENESCENCE IN THE LUNGS OF THE OFFSPRING 
 
3.8.1 Cellular Senescence in the Lungs of the Offspring 
Fig. 3.8.1 illustrates the effect of aging, gender, as well as nicotine, tomato juice, 
and exposure to both nicotine and tomato juice on senescent cell count/100μm 
length of alveolar wall. At postnatal day 14, the number of senescent cells/100μm 
was the same as for the control and experimental groups (P>0.05). At postnatal 
days 42 and 84, no differences were observed between the control, and the 
experimental animals exposed to tomato juice only, or to both nicotine and tomato 
juice (P>0.05). On the other hand, at postnatal days 42, the nicotine exposed 
offspring had a senescent cell count of 45% (P<0.001) higher at 0.42±0.04 
cells/100µm alveolar walls than that of the control at 0.19±0.02 cells/100µm 
group. At postnatal day 84, the nicotine exposed offspring (0.46±0.03 
cells/100µm) also displayed a significant 47.8% higher (P<0.01) senescent cell 
count when compared with the control group at 0.22±0.09 cells/100µm alveolar 
wall (table 3.8.1) of the same age. 
 
In only the nicotine group, the cellular senescence increased between postnatal 
days 14 and 84 (P<0.05).  The number of senescent cells per 100µm of alveolar 
wall of the other experimental groups between postnatal days 14, 42 and 84, 
displayed no differences (P>0.05). Between postnatal day 14 (0.32±0.03 
cells/100µm) and 42 (0.42±0.04 cells/100µm) of the nicotine exposed offspring, 
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the senescent cell count has increased by 76.1% (P<0.05), and between postnatal 
day 14 (0.32±0.03 cells/100µm) and postnatal day 84 (0.46±0.03 cells/100µm), 
the senescent cell count has increased by 69.6% (P<0.05) in the nicotine exposed 
offspring as well.  
 
Although the number of senescent cells/100µm alveolar wall in the nicotine 
exposed offspring increased from 0.32±0.03 cells/100µm at postnatal day 14 to 
0.42±0.04 cells/100µm on postnatal day 42 (P>0.05), it reached a plateau between 
postnatal days 42 and 84. 
 
Between postnatal days 14 and 42 of the control animals, the number of senescent 
cells decreases from 0.23±0.0 cells/100µm to 0.19±0.02 cells/100µm on postnatal 
day 42. Like for the nicotine group the number of senescent cells per length of 
alveolar wall remains unaltered between postnatal days 42 and 84.  
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Fig. 3.8.1 The effect of maternal nicotine and tomato juice exposure during gestation on the 
senescent cell count (cell/100µm) of the offspring.  
Table 3.8.1 The effect of maternal nicotine, tomato juice, and a combination of nicotine and tomato 
juice during gestation on the senescent cell count (cell/100 µm) of the offspring at 
postnatal days 14, 42 and 84 (below). 
  
 
 
 
 
 
 
 
 
Age (Days)  C C vs. T  T C vs. N  N C vs. NT NT 
14 0.23±0.04 P>0.05 0.25±0.02 P>0.05 0.32±0.03 P>0.05 0.2±0.04 
D14 vs. D42 P>0.05  P>0.05  P>0.05  P>0.05 
42 0.19±0.02 P>0.05 0.17±0.03 P<0.05 0.42±0.04 P>0.05 0.23±0.07 
D42 vs. D84 P>0.05  P>0.05  P>0.05  P>0.05 
84 0.22±0.09 P>0.05 0.2±0.03 P<0.05 0.46±0.03 P>0.05 0.21±0.02 
D84 vs. D14 P>0.05  P>0.05  P>0.05  P>0.05 
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3.9 THE EFFECT OF MATERNAL NICOTINE EXPOSURE AND 
TOMATO JUICE INTAKE DURING GESTATION ON THE 
CONNECTIVE TISSUE IN THE LUNGS OF THE OFFSPRING 
 
The connective tissue framework is essential for the structural integrity of the 
lungs. Fig. 3.9(a) is the control group of day-84-old offspring, and fig. 3.9(b)are 
those animals that were exposed the intake of tomato juice during gestation via 
the mother, at the same age. The connective tissue framework seems intact, 
showing healthy lungs as the rats mature. In fig. 3.9(c), however, there are 
breakages in the connective tissue framework of the lungs of the in 84-day-old 
rats caused by nicotine exposure via the placenta during gestation. Interestingly, 
those animals exposed to both maternal nicotine and tomato juice intake (fig. 
3.9(d)) by the mother during gestation did not show destruction of the connective 
tissue framework in the lungs, suggesting that tomato juice prevented the harmful 
effects of nicotine. 
 
Also, the Cst was higher at postnatal day 84 for both males and females exposed 
to nicotine via the placenta during gestation. The breaks in the connective tissue 
(fig 3.9(c)) resulted in an increased Cst in the nicotine exposed offspring.  
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Fig. 3.9.  Connective tissue stain of lung tissue of the 84-day-old offspring : a) Control, b) Tomato Juice 
Exposed c) Nicotine Exposed , d) Exposed to both Tomato Juice and Nicotine during Gestation. 
Arrows indicate breaks in connective tissue in alveolar walls. 
  
Fig.3.9(a) Control Day-84 Lung  Fig.3.9(b) Tomato Juice Day-84 Lung  
Fig.3.9(c) Nicotine Day-84 Lung  Fig.3.9(d) Nic + Tom Day-84 Lung  
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Breaks in the connective tissue are evident in the alveolar walls of the nicotine 
exposed offspring. No such breaks were evident in the lungs of the controls and 
the other experimental groups (fig. 3.9).  
 
Also, the results in this project points to the fact that the offspring that was 
exposed to nicotine via the placenta during gestation, results in changes in the 
lung parenchyma which resembles emphysema- like lesions in their adult life (fig. 
3.10 (D)). And that the offspring whose mother’s diet was supplemented with 
tomato juice, and who received nicotine via the placenta, showed a preventative 
effect of tomato juice against the adverse consequences of nicotine exposure 
during gestation (fig. 3.10 (C). This indicates that tomato juice is an effective 
supplement that can assist in maintaining the integrity of the lungs of the 
offspring. 
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Fig. 3.10. The influence of maternal exposure to nicotine, tomato juice, and a combination of 
nicotine and tomato juice on lung parenchyma of the 84-day-old offspring.(A) Control. 
(B)Tomato juice. (C) Nicotine and tomato juice. (D) Nicotine. Where arrows indicate 
emphysema-like lesions (Bar =  0.5 mm.) 
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CHAPTER FOUR 
Discussion 
 
4.1 INTRODUCTION 
4.1.1 Smoking Prevalence 
The WHO estimates that there are approximately 1.1 billion smokers worldwide. 
About 800 million of these smokers are in developing countries. An estimate of 
about 50% of men and 8% of women in developing countries are smokers (WHO 
2002).  
 
In South Africa however, prevalence rates for daily adult smoking over the past 
decade have continuously decreased. Adult (15 years smoking history) daily 
smoking rates illustrated a decrease that fell 30.2% in 1995 to 24.1% in 2004. As 
a result, approximately 2.5 million smokers stopped their smoking habits during 
this period (Steyn et al., 2002, van Walbeek, 2002). 
 
4.1.2 Smoking during Pregnancy 
In South Africa, it has been estimated that about 20% of female smokers are 
smoking during pregnancy, of which coloured women had the highest rates  (Steyn 
et al., 1997). At Tygerberg hospital in the Western Cape, smoking during 
pregnancy significantly increased the risk of the two leading causes of perinatal 
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death, namely preterm labour and abruption placentae (Odendaal et al., 2001). Yet 
only 12% of pregnant smokers presenting at the hospital were aware of these 
risks. Unfortunately, only few doctors in the public sector, antenatal services, in 
Cape Town advise their patients about the risks of smoking or quitting the habit, 
whereas the rest do not regard smoking as a priority issue, especially during 
pregnancy (Viljoen and Odendaal, 2005).  
 
4.1.3 Mortality 
In the year 2000, an estimated 4.84 million premature deaths were attributed to 
cigarette smoking, worldwide. Of this 4.84 million, 2.41 million were in lower-
income countries, and 2.43 million were industrialised countries. This measured 
up to 12% of the total global adult (30+) mortality (Ezzati and Lopez, 2003). In 
South Africa about 8% of adult deaths were attributable to smoking in 1998 which 
amounts to approximately 21500 deaths per year during that period. As the 
smoking epidemic is still increasing, it is expected that the proportion of deaths 
from tobacco continues to grow in the near future (Sitas et al., 2004).  
 
In high- income countries, cardiovascular diseases and lung cancer are the main 
causes of death from smoking whereas in South Africa, the leading causes of 
death from smoking are chronic obstructive pulmonary disease (COPD), 
tuberculosis (TB), as well as lung cancer and ischaemic heart disease (IHD) (table 
4.1.3) (Sitas et al., 2004). If people stopped smoking, it is estimated that 
approximately 58% of lung cancer deaths, 37% of COPD, 20% of TB deaths, and 
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23% of vascular deaths could be avoided. Smoking evidently has an impact on 
health in South Africa, and also adversely affects the productivity of individuals 
due to a higher likelihood of hospitalisation of smokers with associated costs to 
the economy (Sitas et al., 2004).   
 
 
 
 
 
 
   Table 4.1.3 Smoking related deaths in 2000 
 
An estimated five million people in the world die prematurely each year as a 
result of tobacco use and tobacco smoke exposure. Epidemiological studies have 
shown that cigarette smoke kills more Americans than alcohol, car accidents, 
suicide, AIDS, homicide and illegal drugs combined (Li et al., 2011). Although no 
data is available, it is plausible that the same is true for South Africa. Deaths of 
infants due to parental smoking are not taken into account in these studies.  
 
4.1.4  Smoking and its Effect on Growth and Development of the Offspring  
Epidemiological studies have shown that an estimated 20% of women persist in 
their smoking habits throughout their pregnancy, even though there are well 
documented information emphasizing the dangers of smoking on the unborn child 
(Steyn et al., 1997). The smoking mother inhales approximate 4000 chemicals in 
tobacco, some of which readily crosses the placenta and entering the fetal 
Disease caused by smoking in 2000 % 
Chronic Obstructive Pulmonary Disease (COPD) 28 
Tuberculosis (TB)  19 
Lung Cancer 13 
 Ischaemic  Heart Disease (IHD) 12 
Cancer o f the Lip, Mouth, Pharynx and Oesophogus 10 
Strokes and Vascular Diseases 9 
Other Conditions 9 
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circulation together with the nutrients. Maternal smoking induces low birth 
weight, and is the principal cause of fetal growth restriction especially in well 
developed countries. Studies have shown that the chemicals inhaled during 
maternal cigarette smoking inhibits fetal growth through direct effects on fetal and 
placental cells, or via altered expressions of hormones and growth factors known 
to be important for fetal growth and development. It has also been shown that a 
risk to low fetal birth weight is directly correlated with nicotine concentrations in 
maternal blood (Gruslin et al., 2009).  
 
The effects of maternal smoking during gestation can be due to multiple factors,  
such as poor nutritional  status since a suppressed appetite can occur as an effect 
of tobacco smoke, as well as the anorexigenic effect of nicotine itself (Wickstrom, 
2007). After absorption of nicotine, distribution of it in the body is rapid and it has 
a particularly high affinity for the brain, heart and lungs (Wickstrom, 2007).  
 
The effect of tobacco smoke during pregnancy allows the compounds contained in 
the cigarette to accumulate in the utero-placental environment, thus affecting the 
developing fetus. Nicotine, the addictive component of tobacco smoke  
accumulates in the developing fetal lung; it not only suppresses energy 
metabolism in the neonatal lung, but also interferes with neonatal lung cellular 
integrity (Maritz and van Wyk, 1997). The consequent inhibition of glucose 
metabolism in the neonatal lung is not due to the inadequate transport thereof, but 
rather due to the suppression of glycolysis which may cause an interference with 
lung development since glycolysis plays an important role in maintaining the 
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integrity of the lung, as well as the supply of energy which is essential for cell 
proliferation to occur in the developing lung (Iba et al., 1999). Glucose, vitamin A 
and vitamin C are essential nutrients for lung development and optimum function 
thereof after birth and into old age (Elsayed, 1987, Nakamura et al., 2012).  
 
Also, studies have shown that glucose is the main source of α-glycerophosphate 
for pulmonary surfactant synthesis. It is, therefore, essential for normal lung 
development, structure, and function in newborns and adults (Maritz and Harding, 
2011). Type II alveolar epithelial cells are the main source of surfactant. In the 
fetal lung, surfactant is produced in increasing quantities towards the end of 
gestation and after birth, from glycogen resulting in a lecithin/sphingomyelin 
increase. This means that the glucose supply during gestation is essential to build 
up the glycogen stores of the lung for surfactant synthesis to prepare the lungs for 
birth. Inadequate glucose supply during fetal lung development may result in 
compromised surfactant synthesis. Studies have indeed shown that cigarette 
exposure of rats led to lower production of surfactant in the lung tissue (Rooney, 
1984). This might be attributed to nicotine by virtue of its inhibitory effect of 
glycolysis and glycogenolysis (Maritz and Harding, 2011). 
 
It has also been shown that maternal nicotine exposure during gestation causes 
alterations in lung structure and lung surfactant which may be important in the 
pathogenesis of impaired pulmonary function in infants and children exposed to 
tobacco smoke due to parental smoking or nicotine replacement therapy (NRT)  
(Chen et al., 2004).  
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From the above it is clear that strategies to assist smokers to quit are important so 
that the general health of a population can be improved. Some health 
professionals prescribe nicotine replacement therapy (NRT) as a strategy to assist 
smokers, including pregnant women, to quit. However, studies implicated nicotine 
in tobacco smoke, as the cause of lower birth weight and compromised lung 
function of the offspring of smokers. It has been shown that maternal nicotine 
exposure during alveolar formation adversely affects lung structure in the longer 
term (Windvogel., 2007), which may affect lung structural integrity and function 
in the longer term. The alveolar phase of lung development is preceded by other 
phases of the lung starting with the embryonic phase, followed by the 
pseudoglandular phase and saccular phases (Jeffrey, 1998).  The latter phase is 
followed by the alveolar phase. The aim of this study was therefore to establish 
whether maternal nicotine exposure up to the saccular phase will interfere with 
lung development, and if so, whether it will return to normal as the lung matures. 
A further objective was to develop a strategy to prevent the adverse effects of 
maternal nicotine exposure during pregnancy on the lungs of the offspring.  
 
4.2 MOTIVATION FOR THE USE OF 1mg NICOTINE/kg BODY 
WEIGHT/DAY 
The daily nicotine intake of human males and females who smoke tobacco varies 
between 10.5 and 78.6 mg (Kurtoglu et al., 2007). Based on the assumption that 
90% of nicotine is absorbed by inhalation (Duan et al., 1991), the nicotine intake 
of a 60kg female will be between 0.16 and 1.18mg nicotine/kg body weight/day. 
The dose used in this study (1mg nicotine/kg pre-pregnancy weight/day) was 
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therefore within the range of intake of habitual smokers. Because nicotine readily 
crosses the placenta and occurs in the milk of the human and rat mother (Maritz 
and Harding, 2011), the fetal rats, like in humans, will be exposed to nicotine via 
the placenta. Studies have shown that the breast milk from human smoking 
mothers contains a mean of 33.1ng/ml (Stepans and Wilkerson, 1993). It has also 
been shown that the milk/plasma nicotine ratio after smoking is 2.9. In humans 
the amount of nicotine transferred to the infant via the mother’s milk increases 
from 0.09 to 1.03μg/kg infant body weight when mothers smoke before breast 
feeding and the daily dose of nicotine via the mother’s milk was 6μg/kg body 
weight (Stepans and Wilkerson, 1993, Maritz and Harding, 2011). 
 
Since nicotine readily crosses the placenta and occurs in the milk or rats, and 
since the dose of nicotine used in this study is within the range of intake by human 
smokers, it is conceivable that the nicotine content of the female rats was the same 
as that for humans. This means that the perinatal and postnatal exposure to 
nicotine of the rat pups in all likelihood resembled that of human offspring. The 
data generated in this study can therefore be assumed to be the same as the effects 
of nicotine, inhaled by smokers, on the offspring. 
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4.3 THE EFFECT OF TOMATO JUICE ONLY, NICOTINE ONLY, OR     
BOTH NICOTINE AND TOMATO JUICE ON GROWTH AND 
DEVELOPMENT 
 
4.3.1 The Pregnant Female 
The nutritional status of the mother is used as a nutritional barometer by the fetus 
to prepare for the world outside the womb. Any interference with the mother’s 
nutritional status or her health may thus impact on the development of the fetus. 
Reports have indeed shown an association between disturbances in the offspring’s 
cardiovascular health, such as hypertension, to poor maternal health. Various 
studies have, for example, also shown that maternal obesity during pregnancy is 
related to adverse perinatal outcomes which may persist for several generations  
(Thangaratinam et al., 2012). Therefore, it is conceivable  that any changes in 
body weight or body composition of the pregnant mother due to nicotine exposure 
will also have an effect on the development of the offspring and consequently the 
health thereof (Thangaratinam et al., 2012).  
 
In this study, no significant differences were observed between mothers receiving 
tomato juice only, or both nicotine and tomato juice during gestation. However, 
the body weights of the mothers receiving nicotine were slightly lower than the 
rest of the experimental groups throughout gestation. This could possibly be due 
to the anorexic effects of nicotine slightly suppressing appetite, thereby 
decreasing body weight. As a result, nutrient intake may also be lowered, which 
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may affect the developing fetus. Supporting studies have indeed shown that 
nicotine decreases food intake (Mineur et al., 2011).  
 
Interestingly, pregnant mothers receiving both nicotine and tomato juice, had no 
effect on body weight of the offspring. This suggests that tomato juice containing 
anti-oxidants such as lycopene and other phytonutrients, assisted in preventing 
appetite and weight loss, thereby ensuring that sufficient quantities of nutrients are 
transported to the developing fetus via the placenta. 
 
4.3.2  The Offspring  
4.3.2.1  Body Weight (BW) 
The BW of the offspring increased gradually after birth. Only from postnatal day 
42, gender differences were observed. This suggests that the growth and 
development of the males and females were the same up to postnatal day 42, 
which means all metabolic and growth control mechanisms, was the same. After 
postnatal day 42 however, the increase in the body weights of the females slowed 
down. It is interesting to note that at postnatal day 84, the body weights of the 
male and female rats that were exposed to nicotine via the placenta was higher 
than that of the control animals of the same age. 
 
Smokers generally gain weight once they quit the smoking habit. This may be due  
to an increase in appetite as well as metabolic rate after nicotine has been 
eliminated from the body (Audrain-McGovern and Benowitz, 2011). It has been 
shown that early life chemical exposures may induce obesity and type II diabetes  
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in the offspring (Fernandez-Twinn and Ozanne, 2006). These exposures to foreign 
chemicals that change the in utero environment within which the fetus develops 
may have a significant impact on the metabolism and health of the individual in 
the long term. An example is that maternal smoking during pregnancy produces 
metabolic programming that leads to an increased risk of obesity in the offspring 
(Al Mamun et al., 2006). In a study by Ferrara et al (2001) it was found that 
smoking cessation for 4 weeks was accompanied by an increase in BW and the 
activity of adipose tissue lipoprotein lipase (AT-LPL). The increase in AT-LPL 
activity suggests an increase in the efficiency of the body to store energy in the fat 
stores of the body and of weight gain. This increase in the efficiency to store fat is 
not accompanied by an increase in lipolytic activity which further increases the 
efficiency of fat storage. These are plausible explanations why the offspring in 
this study that were exposed to nicotine via the placenta, had increased BW at 
postnatal day 84. Interestingly, at postnatal day 42, the BW of the nicotine 
exposed offspring had BW similar to that of the control. Yet, upon reaching 
postnatal day 84, their BW significant increased when compared to the rest of the 
experimental groups of the same age. This suggests that weight gain is indeed 
followed by nicotine withdrawal (Fornari et al., 2007), even though these animals 
were only exposed to nicotine via the placenta during gestation. Importantly, the 
late increase in BW of the nicotine exposed offspring suggests that the offspring 
were programmed during pregnancy to be more susceptible to obesity later in life. 
It is interesting to note that this effect of maternal nicotine exposure on the BW 
gain of the offspring later in life was prevented by supplementing the diets of the 
pregnant mothers with tomato juice. This implies that by maintaining the anti-
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oxidant capacity of the mother and fetus during pregnancy prevented the 
programming of the fetus to become obese later in life.  
 
The BW of human smokers gradually increases after quitting, gaining between 3.2 
and 8.8kg within 8 years of smoking (Audrain-McGovern and Benowitz, 2011) 
and it is possible that nicotine in tobacco smoke is the causative factor.  
 
It is plausible that nicotine induce a metabolic adjustment which favours an 
increase in BW after quitting. This adjustment is prevented by tomato juice.  The 
question is though why nicotine exposure during pregnancy only resulted in an 
increased BW of the male and female offspring as opposed to those who were 
exposed to nicotine during gestation and lactation or lactation only where BW was 
not affected (Maritz and Windvogel, 2003).  
 
4.3.2.2   Lung Volume and Chest Circumference 
From birth up to postnatal day 42, lung volumes of the offspring increased in a 
similar trend as in the body weights. No male or female differences were 
observed. Since the increase in body weight allows for an increase in the oxygen 
demand of the body, lung volumes will increase and a concomitant increase in 
alveolar formation and a consequent equivalent increase in the surface area for gas 
exchange in the lungs (Forrest, 1970). Although the body weights of the female 
rats were lower than that of the males at the same age, the lung volume/body 
weight ratio was the same for control male and female rats because of the possible 
lower oxygen requirements/demands of the females at postnatal day 84.   
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Studies have shown that chest dimensions and pulmonary function are positively 
correlated in healthy individuals (Borkan et al., 1981). On the other hand, older 
smokers were characterised by larger chests than non-smokers or former smokers. 
Younger smokers, however, showed no differences in chest dimensions among 
men (Borkan et al., 1981). This might be due to the shorter time that they were 
smoking, was too short for nicotine to induce a gradual increase in the chest 
circumference of these smokers. In this study, however, it has been demonstrated 
that the chest circumference of young rats born from mothers that were exposed to 
nicotine during pregnancy, was initially smaller than that of the control animals of 
the same age up to postnatal day 21. Contrary to this the chest circumference of 
the mature nicotine exposed offspring (postnatal day 84) was larger than that of 
the control animals. This is difficult to explain since after weaning on postnatal 
day 21, the animals were not exposed to nicotine. However, if chest size is a 
reflection of lung volume, it can be expected that it is due to the bigger volumes 
of the lungs of the 84-day-old nicotine-exposed offspring. This is supported by the 
observation that the chest circumference/lung volume ratio of the control male 
and female rats at postnatal day 84 was the same as for those rats exposed to 
nicotine via the placenta. This means that the increase in chest circumference of 
these nicotine exposed rats was proportional to the increase in lung volume. The 
impact of maternal nicotine exposure during pregnancy on the chest 
circumference of the offspring was, like for the increase in the lung volume, not 
prevented by supplementing the mother’s diet with tomato juice.  
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The crown rump length (CRL) of the offspring was also not affected by maternal 
nicotine exposure or the use of tomato juice as a supplement during pregnancy. 
This was in contrast to the increased body weight of the 84-day-old nicotine 
exposed rats. What this observation implies is that the increase in body weight 
was not due to an increase in the overall size of the body of the nicotine exposed 
offspring. There are two possible explanations for the increase in BW despite the 
fact that the CRL was not affected by maternal nicotine exposure during gestation, 
namely: 1) it is likely that it is due to an increased capacity to store fat, and 2)  it 
has been shown that nicotine have anti-diuretic properties (Burn et al., 1945) 
which implies that the increased body weight of the older animals can partly be 
attributed to water retention. More research into this effect of maternal nicotine 
exposure on BW changes in the offspring is required because of possible health 
consequences for the offspring in the longer term of smoking mothers or mothers 
using NRT. 
 
4.4 THE EFFECT OF MATERNAL NICOTINE EXPOSURE DURING 
PREGNANCY ON LUNG DEVELOPMENT IN THE OFFSPRING 
 
4.4.1 Lung Structure 
The lungs of rats are still in the saccular phase of lung development at the time of 
birth (Joshi and Kotecha, 2007). The walls of the saccules are thick due to a 
double capillary layer. At postnatal day 4, rapid alveolar formation commences in 
rats and ends at postnatal day 13 (Schittny et al., 2008). Following postnatal day 
13, alveolar formation continues to take place as the animal grows, but at a much 
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slower rate. The double capillary layer converges into a single layer during 
alveolarisation and maturation, allowing the alveolar walls to become thinner. 
This offers explanation for the decrease in tissue volume as the lungs of the 
offspring mature. While the tissue volume of the control lungs reached a plateau 
after postnatal day 21, the tissue volume of the animals that were exposed to 
nicotine via the placenta decreased further after postnatal day 42. This was 
followed by an increase in the volume of the air component of the lungs of the 
nicotine exposed animals. The decrease in the tissue volume of the nicotine 
exposed rats was due to a slow but gradual breakdown of the lung parenchyma as 
illustrated by the appearance of microscopic emphysema in the lungs of the 
offspring at around postnatal day 42. The maintenance of the constant tissue 
volume from postnatal day 21 in the control animals is due to a balance between 
formation of new parenchymal tissue and degradation thereof. On the other hand, 
the gradual decrease in the volume of the lung parenchyma of the nicotine 
exposed lungs can be ascribed to faster tissue degradation than t issue formation. It 
is important to note that the offspring of the nicotine exposed mothers received 
nicotine only up to birth. After birth the offspring never received any nicotine.  
Nicotine only has a half- life of 90 minutes (Fontaine, 2005), therefore, it is highly 
unlikely that any nicotine was still present in the lungs of the offspring at 9 weeks 
after nicotine exposure was stopped. This implies that maternal nicotine exposure 
during pregnancy programmed the lungs of the offspring to degrade faster than 
that of the control animals. This means that impaired tissue homeostasis gradually 
developed in these animals followed over time with an imbalance between tissue 
regeneration and tissue degeneration. This becomes apparent at around postnatal 
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day 42 when emphysema-like lesions appear in the lungs of the mature nicotine 
exposed offspring. 
 
Although most research in the past has solely referred to alveolar tissue, it is 
important to note that lung parenchyma also consists of bronchioles, bronchi, 
blood vessels, as well as interstitium. However, the largest component consists of 
the alveolar component. Alveoli, which are large in number, are thin-walled, 
allowing for an enormous surface area for proper gas exchange to be maintained. 
This implies that if degradation of the lung parenchyma exceeds the replacement 
of parenchymal tissue, alveolar size and numbers will be adversely affected with a 
consequent decrease in the surface area available for gas exchange. In this study it 
was indeed demonstrated that the alveolar size, as indicated by the mean linear 
intercept (Lm), of the control animals decreased as the animals’ age due to 
formation of new alveoli. Contrary to this, the alveolar size of the rats that were 
exposed to nicotine via the placenta increased over time. This is an indication of 
alveolar wall destruction with a consequent increase in the alveolar volume and a 
decrease in alveolar numbers in the lungs of the nicotine exposed offspring. 
Consequently while the alveolar number of the control and tomato juice groups 
increased over time, that of the nicotine exposed animals was considerably lower 
than that of the control animals. These effects of maternal nicotine exposure 
during gestation were observed after weaning on postnatal day 21 and gradually 
worsened as the animals aged. Since no nicotine is present in the body, these 
observations suggest that nicotine exposure during gestation interfered with the 
genetically determined processes that are responsible for maintenance of lung 
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structure and function. This interference can be at DNA level, or epigenetic level 
or both since nicotine is genotoxic (Maritz and Harding, 2011). It also increases 
the oxidative stress in the offspring (Bruin et al., 2008).  Nicotine also displays 
antioxidant activity (Newman et al., 2002). 
 
Therefore, since nicotine and the oxidants are able to induce DNA damage such as 
strand breaks (Jorgensen et al., 2010), it may result in transcriptional mutagenesis. 
Nicotine also impair DNA repair (Sellappa et al., 2009).  It also induces 
epigenetic changes (Maritz and Harding, 2011). Taken together these effects of 
nicotine may have important implications for biologic systems such as the 
respiratory system in that it may result in programming an imbalance between 
tissue degradation and synthesis.  
 
It has already been determined that DNA damage induced by reactive oxygen 
species is involved in aging and various human diseases (Kregel and Zhang, 
2007). If this is so, it explains why tomato juice rich in lycopene and the 
phytonutrients associated with its anti-oxidant function, protects the lung against 
the adverse effects of nicotine on the lungs of the offspring of mothers that were 
exposed to nicotine during pregnancy. It is therefore conceivable that nicotine, 
and thus NRT, may induce DNA damage that may render the respiratory system 
more prone to premature aging and thus increased susceptibility to respiratory 
disease.  
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The connective tissue framework of the lung is important for maintenance of lung 
structure and function. The extracellular matrix is an important component of the 
lung parenchyma, which has regulatory effects on cellular physiology, leading to 
reorganization and remodelling of the extracellular matrix, in turn, having an 
effect on lung function (Faffe and Zin, 2009). The major components of 
connective tissue are collagen, elastin, proteoglycans, and glycosaminoglycans 
(Mercer and Crapo, 1990). Collagen, especially collagen type IV is an important 
protein on the basement membrane of the extracellular matrix (Jalali et al., 2010). 
In my study, the offspring exposed to nicotine via the placenta during gestation 
showed a low connective tissue content in the lungs at postnatal day 84. 
Supporting studies have shown that as nicotine crosses the placenta barrier and 
occurs in the mother’s milk during lung development of the offspring, it causes 
adverse effects on the connective tissue of the lung (Jalali et al., 2010).  
This implies that not only maternal smoking, but NRT as well can damage the 
connective tissue framework of the lungs of the offspring, consequently affecting 
lung structure maintenance, and function in the long term. 
 
4.4.2 Cellular Senescence 
From the saccular phase to the alveolar phase of lung development, interstitial 
fibroblasts play a critical role. Type II cell proliferation and the formation of Type 
I cells also occur as part of the process whereby new alveoli are formed. During 
this transition from the one phase to the other, the number of interstitial fibroblasts 
in the neonatal lung of the rat increased 4-fold (Jauniaux et al., 1999). Therefore, 
any interference with fibroblast proliferation and function in the developing lung 
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will not only impact on lung growth and development, but also its role in the 
maintenance of lung structural and functional integrity. Studies have shown that 
perturbations such as hypoxia, barotrauma, and steroid therapy interferes with 
alveolar formation in the rat (Luck et al., 1985), baboon (Murdzoska et al., 2010), 
and human infants (Maritz et al., 2011). These perturbations which are significant, 
often permanent, decreases the number of alveoli and thus the surface available 
for gas exchange. The smaller the surface area available for gas exchange, the 
lower the lung capacity of the individual would be, and consequently it will not 
meet the increasing demand for oxygen by the body during exercise.  
 
An important function of fibroblasts is the formation of mature alveoli, as well as 
supplying the 3D connective tissue scaffold to support the lung and thereby 
maintain structural stability that is important for optimal lung function. A 
significant component of the 3D scaffold is the elastic fibres in the lung, which 
plays an important role in alveolarisation. Fibroblast-Type II cell communication 
is also essential for alveolar formation and maintenance (Fehrenbach, 2001) 
Studies have shown that the inhibition of elastic fibre assembly has been linked to 
impaired septation (Raunio et al., 1999). Damage to the elastic tissue 
compartment or impaired formation of this compartment due to impaired 
fibroblast function and communication with Type II alveolar epithelial cells will 
thus impair alveolar formation and maintenance.  This will result in larger, but 
fewer alveoli in the lungs, as well as a decrease in the surface available for gas 
exchange. In neonatal lung fibroblasts of the rat, elastin expression is the highest 
during the phase of rapid alveolarisation, and declines rapidly thereafter 
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(Gamieldien and Maritz, 2004). This suggests that interference with lung 
fibroblast integrity may result in impaired lung development.  
 
Fibroblast proliferation and migration is inhibited by exposure to tobacco smoke, 
by increasing the cell cycle transit time, thus reducing the rate of alveolarisation.  
Consequently a smaller internal surface area available for gas exchange can be 
expected in the lungs of neonates born to parents that smoke. Tobacco smoke 
exposure also compromises fibroblast- induced repair responses, which may be a 
factor that contributes to the development of smoke induced diseases (Carmella et 
al., 1997) such as emphysema and asthma. Furthermore, nicotine also accumulates 
in the lung fibroblasts which cause glycolysis to be suppressed, in turn further 
compromising the role of fibroblasts to maintain alveolarisation and lung structure 
maintenance in the long term. This will eventually result in a compromised lung 
function.  
 
Research has shown that studies done in vitro displayed no effects on the 
fibroblasts of human fetal lungs when exposed to nicotine (Carmella et al., 1997). 
On the other hand, in vivo studies also shown that nicotine had no long-term effect 
of metabolism in the lungs of adult animals as opposed to permanent suppression 
of energy metabolism of animals that were exposed to nicotine during lung 
development (Maritz and Burger, 1992). These in vitro studies were performed on 
cells that were not metabolically permanently compromised as oppose to the 
fibroblasts of lung cells of neonatal rats that had been exposed to nicotine during 
gestation and lactation. 
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Since studies have confirmed that maternal nicotine exposure during gestation and 
lactation interferes with glucose metabolism and apoptosis in the fetal and 
neonatal lung (Kordom et al., 2003), and that it may cause disruption of the 
interaction between lung fibroblast glucose metabolism and fibroblast function 
(Maritz and Harding, 2011), it is plausible that it will also adversely affect the 
long-term maintenance of lung structure.  
 
Interestingly, it has also been shown that patients with emphysema, showed a 
reduced proliferation rate of their lung fibroblasts (Holz et al., 2004) as well as 
premature aging (Muller et al., 2006). Therefore, it is conceivable that the gradual 
deterioration of the connective tissue framework of the lungs of those rat pups that 
were exposed to nicotine via the placenta was partially due to compromised 
fibroblast proliferation and premature aging. Premature aging of the cells in the 
alveolar wall may also reduce the number of, for example fibroblasts, which are 
capable of proliferation and thereby reduce the capacity of the alveolar wall to 
maintain itself. A consequence of this is a slow degradation of the lung 
parenchyma. 
 
Glycolysis plays an important role in the maintenance of lung cells (Lunt and 
Vander Heiden, 2011). Studies have shown that glycolysis is suppressed in 
animals exposed to maternal nicotine during gestation and lactation, with a 
consequent reduction of glucose flux through the glycolytic pathway (Maritz, 
1987). Additionally, AMP (adenosine monophosphate) also accumulated in the 
lungs of the nicotine exposed rat pups. Subsequently, the AMP content of the 
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lungs of the nicotine exposed offspring increased even after the withdrawal of 
nicotine  (Maritz and Burger, 1992). Studies have shown that the onset of 
premature cell senescence is associated with persistent reduced glycolytic activity 
as well as high levels of AMP (Kondoh et al., 2005a, Zwerschke et al., 2003).  
Supporting studies shows that enhancement of glycolysis bypasses cellular 
senescence (Kondoh et al., 2007). Therefore, it is conceivable that maternal 
nicotine exposure during gestation induce premature aging of the lungs of the 
offspring by irreversible suppression of glycolysis and the persistent high levels of 
AMP in the lungs of the offspring (fig. 4.4.2).  
 
The structural integrity of the lung needs to be maintained by replacing the 
alveolar cells lost by apoptosis, with cell proliferation. Studies have shown that 
emphysema is associated with increased levels of alveolar cell proliferation as 
well as apoptosis (Newman et al., 2002). Upon reaching the senescence stage of 
the cell cycle, it causes cell proliferation to stop, thereby not compensating for the 
loss of alveolar cells by apoptosis to be replaced. According to this study, animals 
exposed to nicotine via the placenta during gestation showed signs of cellular 
senescence from as early as postnatal day 14, and the number of senescent 
cells/100µm of alveolar wall had a faster, yet gradual increase up to postnatal day 
84, compared to the rest of the experimental groups that received both tomato 
juice and nicotine via the placenta, tomato juice only, and the control. This 
implies that alveolar cell loss contributes to pulmonary destruction and reduced 
lung surface area in the lungs of the offspring, which are characteristics of 
emphysema-like changes (Newman et al., 2002). Supporting studies have shown 
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that cellular senescence may play a role in changes that occur in the lungs during 
the pathogenesis of emphysema (Tsuji et al., 2006).  
 
Therefore, premature aging and the gradual deterioration of the lung parenchyma 
will compromise lung function. This means that smoking and NRT will program 
the lungs of the offspring to become structurally and functionally compromised 
due to premature aging of the cells of the alveolar wall.  
 
        AMP 
 
NICO TINE   ROS      Premature Aging 
 
         DNA Damage       Glycolysis 
 
Fig.4.4.2. Diagram to illustrate the metabolic changes that induces premature aging in of the lung 
parenchyma of rats exposed to nicotine via the placenta and mother’s milk.   
 
4.5 LUNG FUNCTION 
Lung function and lung structure are in close relation to each other (Berend et al., 
1981). This suggests that changes in structure of the lungs may have adverse 
effects on the function of the lungs. As described in the results of this study, a 
decrease in alveolar number and the consequent decrease in internal surface area 
available for gas exchange imply that the diffusion capacity for oxygen of the 
lung of the nicotine exposed offspring will be compromised in the long term. 
Diffusion capacity is a measure of how effectively oxygen and carbon dioxide are 
transferred across the blood-air barrier between the lungs and the blood. During 
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exercise, the body has an increased demand for oxygen. However, if there is a 
decrease in the alveolar number due to factors such as cigarette smoke, the lungs 
will thus have a smaller internal surface area available for gas exchange, which 
may adversely impact the ability of such individuals to execute strenuous 
exercises.  
 
In this study the static compliance of the lungs of the control male and female and 
those born to mothers that received tomato juice supplementation during gestation 
was the same. Compliance was also not affected for those rats that were exposed 
to nicotine via the placenta up to postnatal day 42. However at postnatal day 84 
the compliance of the male rats was markedly higher than that of the control 
animals of the same age. The compliance of the female rats was not affected 
though. The reason for this gender difference in response to maternal nicotine 
exposure is not known.  
 
From the data it appears that the increase in the compliance of the nicotine 
exposed offspring is only observed later in the life of the offspring, and at a stage 
when the structural integrity was compromised most. It is plausible that as the 
animals age, compliance will further increase due to the gradual deterioration of 
the lung parenchyma, due to elastic tissue damage. Although no direct evidence is 
available, it is conceivable that premature senescence of fibroblasts and other cells 
in the alveolar walls will result in a gradual deterioration of the alveolar walls 
with the development of emphysema-like lesions. Also, emphysematous lesions, 
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as shown in this study, are associated with degradation of the elastic tissue which 
will adversely affect lung recoil.  
 
4.6 EFFECTS OF TOMATO JUICE 
Many females resort to nicotine replacement therapy (NRT) to quit their smoking 
habits, even during pregnancy. Studies have shown that nicotine readily crosses 
the placenta and is present in the fetal circulation and amniotic fluid at higher 
levels than in the maternal circulation (Sastry et al., 1998). This suggests that the 
mere intake of nicotine, whether it is via smoking or NRT, changes the in vitro 
environment within which the fetus develops by reducing the anti-oxidant 
capacity of the mother as well as in the developing fetus or neonate. It also 
increases the oxidant levels in the in utero environment and the fetus (Aycicek et 
al., 2005).  Therefore if the oxidant-antioxidant balance of the mother, fetus, and 
offspring can be restored by supplementing the diets with antioxidants, it will be 
possible to prevent the adverse effects of nicotine on lung development.  
 
There is a large body of epidemiological evidence suggesting that tomatoes 
contain several antioxidants that may reduce the risk for oxidant associated 
diseases. These antioxidants include ascorbic acid, vitamin E, carotenoids, 
flavonoids, as well as phenolic acids. The disease-preventing potential of a food, 
such as tomatoes, is a consequence of several such constituents which may show 
some synergistic interactions (Erdman et al., 2009). This implies that one 
micronutrient, together with other micronutrients in the correct ratios may be 
much more effective as opposed to supplementing an individual’s diet with a 
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single micronutrient only. Research studies has in fact shown that pure lycopene 
is not as effective as an antioxidant when used on its own, compared to when it is 
in the presence of the phytonutriets such as tomatoes (Bjelakovic et al., 2008). 
Experimental research has indeed shown that supplementing the diet of adult rats 
with antioxidants and phytonutrients, prevented nicotine induced damage to the 
lung parenchyma of rats (Kasagi et al., 2006).  Therefore, one of the aims in this 
study was to establish whether the oxidative effect on the lungs caused by nicotine 
can be prevented by the anti-oxidant properties in tomato juice in the lungs of the 
offspring. The diets of the mothers in this study was supplemented with tomato 
juice containing trans- lycopene, a potent anti-oxidant, as well as other 
phytonutrients and vitamins to work effectively against the harmful effects of 
nicotine administered during gestation.  
 
As a result, the supplementation of tomato juice in the mothers’ diet during 
gestation had no effect on the growth and development of the offspring. Tomato 
juice also showed no effect on the structural development of the lungs in the 
offspring, thereby preventing the adverse effects of nicotine exposure via the 
placenta as well maintaining the average rate at which the animals’ age. This 
suggests than not only maternal smoking, but also NRT should not be an option 
for pregnant mothers, and that supplementing the diet with tomato juice 
throughout pregnancy for those who are trying to quit the smoking habit could 
prevent severe damage to the lungs and general health in the postnatal life of the 
offspring. 
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It is evident that in this study, stress- induced cellular senescence was caused by 
the harmful effects of nicotine in the lungs of the offspring via the placenta, 
allowing DNA damage and oxidative stress to worsen as the animals’ age. 
However, tomato juice supplementation with nicotine administration via the 
placenta showed no increase in the senescent cell count/100µm of alveolar wall in 
the lungs of the offspring from postnatal day 14 up to postnatal day 84. This 
implies that tomato juice, containing lycopene and other phytonutrients, prevented 
alveolar cells from reaching a state of cell senescence, which means that apoptosis 
and proliferation continued to function normally even though the rats was exposed 
to nicotine via the placenta during gestation.  
 
In view of the fact that tomato juice supplementation in the mother’s diet had no 
effect on the lung development and aging in the offspring up to postnatal day 84, 
it implies that upon reaching lung maturation, further damage is less likely to 
occur. This also suggests that those animals exposed to nicotine via the placenta 
during gestation only, surely experienced the adverse effects thereof, such as 
increased body weights, increased lung volumes, increased cellular senescence 
and decreased lung surface area and decreased alveolar numbers] in their adult 
life. This confirms that a change in the ‘program’ of lung development was altered 
in utero. And it also confirms that tomato juice is able to prevent such detrimental 
effects on the respiratory health of the offspring.  
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4.7 NICOTINE REPLACEMENT THERAPY (NRT) 
As a result of the dangers of smoking, NRT is now widely promoted by health 
practitioners as a safe way to quit smoking. However, many studies illustrate that 
nicotine indeed interferes with the development of the fetal lungs, heart, as well as 
the central nervous system. Nicotine is genotoxic (Argentin and Cicchetti, 2004, 
Kleinsasser et al., 2005) and studies have shown that its toxic effects persists in 
the fetus even after administration thereof has stopped (Maritz, 2002). In 
monkeys, research has shown that the damaging effects of nicotine during 
pregnancy increases the development of α7 nicotinic receptors in cells implicated 
in lung development (Sekhon et al., 1999). This implies that more nicotine 
molecules can enter these cells to interfere with metabolism and organelle 
integrity and function. 
 
Studies have also shown that lysyl oxidase activity is suppressed by maternal 
nicotine exposure, consequently contributing to the gradual deterioration of the 
lung parenchyma of the offspring. Nicotine also induces peroxidation of 
membrane lipids (Kalpana and Menon, 2004) which changes the 
oxidant/antioxidant status of the lungs of the offspring. This is supported by the 
decrease in the vitamin C and E content of the lungs of the offspring (Maritz and 
Rayise, 2011). Studies also show a clear decrease in the levels of enzymes that 
catalyze the removal of antioxidants from the lung. Research done in our 
laboratories have shown that the level of superoxide dismutase in the lungs of rats 
that were exposed to nicotine via the mother’s blood remains significantly lower 
than that of rats not exposed to nicotine (unpublished data). This implies that apart 
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from its immediate effect in the lungs of those who use NRT, nicotine intake 
during pregnancy and lactation will have a long-term effect on the maintenance of 
lung integrity and respiratory health of the offspring (Bruin et al., 2008).  
 
4.8 IMPACTS ON THE HEALTH OF THE OFFSPRING IN THE 
LONG TERM 
Even though more research regarding the long-term effects of NRT in humans are 
required, there is a substantial amount of evidence in animal studies which 
signifies that fetal and neonatal exposure leads to widespread postnatal health 
consequences. In animal experimental research, it has been shown that maternal 
nicotine exposure during gestation and lactation had an effect of the pulmonary, 
cardiovascular, reproductive, metabolism as well as hypoxia-sensing outcomes in 
the offspring (Bruin et al., 2010).  
 
Interestingly, the adverse effects of maternal nicotine are not limited to the first 
generation offspring (F1). Studies have shown that maternal nicotine exposure 
also appears to affect the second generation of offspring (F2), where the mothers 
of the F2 generation had elevated blood pressure, increased fasting serum insulin, 
as well as an enhanced insulin response to an oral glucose challenge (Holloway et 
al., 2007).  
 
It is therefore important not to only consider the effect of smoking or NRT on the 
lungs of the respiratory health of the first generation progeny, but also on the 
subsequent generations. The long term implications should therefore be 
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considered by health authorities when making policy decisions regarding the 
safety if NRT especially during pregnancy.  
 
 
4.9 CONCLUSION 
In conclusion, the outcomes of my study showed that maternal nicotine exposure 
during gestation resulted in a change in the program that controls aging of the 
lungs of the offspring. Consequently, this renders the lungs more susceptible to 
disease and reduces lung function. Based on findings of other studies done in our 
laboratories, the effect of nicotine on lung development is also transferable 
between generations. This is conceivable due to a combination of placental 
changes as well as the direct effect of nicotine on cell DNA. It is therefore not 
advisable to prescribe NRT to pregnant and lactating women. However, a more 
relative approach would be to ensure that the antioxidant capacity of pregnant and 
lactating women are maintained, as it will protect the fetus and neonate against the 
adverse effects of oxidants in the atmospheric air and especially in tobacco 
smoke. 
 
More data generated in this particular study will provide a better understanding 
and interpretation of results concerning the sites of mechanism of action of 
nicotine intake by the mother and on the lungs of the offspring as well as the long 
term consequences regarding the susceptibility of these lungs to damage, as well 
as the irreversible growth arrest of cellular senescence.  It will also further confer 
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evidence as to why NRT is not an option to stop the smoking habit, especially in 
pregnant and lactating females. 
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